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A B S T R A C T
Background
Intramedullary nails may be used for the surgical fixation of extracapsular hip fractures in adults.
Objectives
To compare different types or design modifications of intramedullary nails used in the fixation of extracapsular hip fractures.
Search strategy
We searched the Cochrane Bone, Joint and Muscle Trauma Group Specialised Register (June 2007), the Cochrane Central Register
of Controlled Trials (The Cochrane Library 2007, Issue 2), MEDLINE (1966 to June week 3 2007), EMBASE (1988 to 2007 Week
27), the UK National Research Register, Current Controlled Trials, orthopaedic journals, conference proceedings and reference lists of
articles.
Selection criteria
All randomised or quasi-randomised trials comparing different types of intramedullary nails or modifications to the design of in-
tramedullary nails in the treatment of extracapsular hip fractures in adults.
Data collection and analysis
Both authors independently assessed trial quality and extracted data. Additional information was sought from all trialists.
Main results
Nine studies, involving a total of 1290 predominantly female and older people with mainly unstable trochanteric fractures, were
included. Allocation concealment was confirmed in only one trial.
Four studies (910 participants) compared the proximal femoral nail with theGammanail. There was no statistically significant difference
between the two implants in operative fracture of the femur (1/455 versus 5/455; relative risk 0.33, 95% confidence interval 0.07 to
1.63) nor differences for fracture healing complications, reoperations, other post-operative complications, mortality or function.
Two studies (185 participants) found no notable differences between the ACE nail versus the Gamma nail. One study (34 participants,
all under 50 years) found no difference between the Recon nail versus the long Gamma nail. One study (80 participants) found
no differences between a gliding nail versus a standard Gamma nail. Another study (81 participants) found no difference between a
dynamically versus a statically locked intramedullary hip screw.
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Authors’ conclusions
The limited evidence from the randomised trials undertaken to date is insufficient to determine whether there are important differences
in outcome between different designs of intramedullary nails used in the internal fixation of extracapsular hip fractures. Given the
evidence of superiority of the sliding hip screw compared with intramedullary nails for extracapsular hip fractures, further studies
comparing different designs of intramedullary nails are not a priority. Any new design should be evaluated in a randomised comparison
with the sliding hip screw.
P L A I N L A N G U A G E S U M M A R Y
Intramedullary nails for extracapsular hip fractures in adults
Fractures of the upper part of the thigh bone (femur) are termed hip or proximal femoral fractures. Roughly half of all hip fractures
are ’extracapsular’ in that they lie outside the hip joint capsule. These fractures may be surgically fixed using metal implants. One type
of implant is the ’intramedullary nail’. This consists of a metal rod, which is usually inserted from the upper end of the femur into the
inner cavity (medulla) of the femur bone and held in place with screws.
This review assessed the evidence from nine randomised controlled trials that compared different designs of these nails. Four trials
compared the proximal femoral nail with the Gamma nail in 910 older adults. Two trials involving 185 older adults compared the ACE
intramedullary nail with the Gamma nail. One trial compared the Recon nail with the Gamma nail in 34 younger adults, all under 51
years old, with high-energy fractures such as from road traffic accidents. For all three comparisons there appeared to be no important
differences in outcome between the two nails under test. One trial of 80 older adults looked at the effects of changing the design of
one of the screws, and another trial of 81 older adults looked at the effects of changing one of the interlocking holes. Both these studies
had too few participants to see if these changes in nail design had an important effect.
So far, the limited evidence from randomised controlled trials has not shown any important differences between the different designs
of nails under test.
B A C K G R O U N D
Hip fracture is the general term for fracture of the proximal (up-
per) femur. These fractures can be subdivided into intracapsu-
lar fractures (those occurring within or proximal to the attach-
ment of the hip joint capsule to the femur) and extracapsular
(those occurring outside or distal to the hip joint capsule). Ex-
tracapsular hip fractures are defined as those fractures that occur
within the area of bone bounded by the attachment of the hip
joint capsule and extending down to a level which is five cen-
timetres below the distal (lower) border of the lesser trochanter.
Other terms used to describe these fractures include trochanteric,
subtrochanteric, pertrochanteric and intertrochanteric fractures.
These terms reflect the proximity of these fractures to the greater
and lesser trochanters, which are two bony protuberances (bulges)
at the upper end of the femur outside the joint capsule.
Numerous subdivisions and classification methods exist for these
fractures (e.g. theAOclassification (Muller 1991)). Themost prac-
tical classification, and that used for this review, is the basic divi-
sion into four types; stable trochanteric fractures (AO classification
type A1), unstable trochanteric fractures (AO classification type
A2), fractures at the level of the lesser trochanter (transtrochanteric
or AO classification type A3) and subtrochanteric fractures. Stable
trochanteric fractures are two part fractures in which the fracture
line runs obliquely (at an angle) between the lesser and greater
trochanter of the femur.Unstable trochanteric fractures again have
an oblique fracture line running between the trochanters but in
addition there is comminution (fragmentation) of the fracture site.
The comminution fragments may be the lesser trochanter, greater
trochanter or both trochanters. Transtrochanteric fractures, sited
at the level of the lesser trochanter, have a slightly more distally
located (lower) fracture line that either runs transversely (across
the bone) at the level of the lesser trochanter or in an oblique di-
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rection that is opposite (or ’reverse’) to that of the stable and un-
stable trochanteric fractures. Transtrochanteric fractures may be
two part or comminuted. This fracture pattern is unstable as the
femur is displaced medially (inwards) due to the pull of the abduc-
tor muscles. Subtrochanteric fractures are those fractures in which
the fracture crossing the femur is predominately found within the
five centimetres of bone immediately below the lesser trochanter.
These fractures may be two part or comminuted and in some in-
stances the fracture may extend proximally into the trochanteric
region or distally into the shaft of the femur.
Operative treatment of hip fractures was introduced in the 1950s
using a variety of different implants. Implants may be either ex-
tramedullary or intramedullary in nature. The most commonly
used extramedullary implant is the sliding hip screw (SHS), which
is synonymous with the term compression hip screw and equiva-
lent models such as the Dynamic, Richards or Ambi hip screws.
Intramedullary nails used for the internal fixation of extracapsular
fractures can either be inserted from proximal to distal (cephalo-
condylic nails) or from distal to proximal (condylocephalic nails).
Cephalocondylic nails are inserted through the greater trochanter
of the femur and secured by a cross pin or screw, which is passed
up the femoral neck into the femoral head. A number of different
designs have been developed and marketed by different manufac-
turers. Examples include the Gamma nail (Stryker-Howmedica),
the intramedullary hip screw (Smith and Nephew Richards), the
proximal femoral nail (Synthes) and the ACE trochanteric nail
(DePuy Orthopaedics).
Successive updates of our Cochrane review (Parker 2008) compar-
ing the Gamma and other cephalocondylic intramedullary nails
with extramedullary implants for extracapsular hip fractures have
consistently found that cephalocondylic nails incur the compli-
cations of intra-operative and later fracture around the implant.
Based primarily on the higher rate of complications and reoper-
ations of these nails for trochanteric fractures, we suggested that
the SHS appears to be the better device for these fractures. We
also suggested that “Further studies are required to determine if
different types of intramedullary nail produce similar results, or
if intramedullary nails have advantages for selected fracture types
(for example, subtrochanteric fractures).”
Condylocephalic nails are inserted into the distal femur and passed
up the intramedullary cavity across the fracture site and up into
the femoral head. The best known and tested type of such nails is
the Ender nail. Our Cochrane review of randomised trials com-
paring these implants with extramedullary fixation (Parker 1998)
concluded that the use of condylocephalic nails could not be rec-
ommended because of the markedly increased risk of fracture-
healing complications and other problems associated with condy-
locephalic nails (in particular Ender nails).
Despite the evidence of poor performance of intramedullary nails
in comparison with the SHS, developments and modifications to
intramedullary nails, especially cephalocondylic nails, continue.
This systematic review of randomised trials examines studies that
have compared different types, or modifications to the design, of
intramedullary nails for extracapsular proximal femoral fractures.
O B J E C T I V E S
Our objective was to compare the relative effects (benefits and
harms) of different designs of intramedullary nails for the treat-
ment of extracapsular proximal femoral fractures in adults.
M E T H O D S
Criteria for considering studies for this review
Types of studies
All randomised or quasi-randomised (for example, alternation)
controlled trials comparing different types of intramedullary nails.
Types of participants
Skeletally mature patients with an extracapsular proximal femoral
fracture. Given that one of the authors (MJP) has become aware of
the growing use of intramedullary nails in intracapsular fractures,
we note here that in a future update we will consider including
trials with a mixed population of intracapsular and extracapsular
proximal femoral fractures.Wewill, however, request separate data
for the two fracture types.
Types of interventions
Surgical fixation of the fracture with either a cephalocondylic
intramedullary nail (for example, the Gamma nail, the in-
tramedullary hip screw (IMHS) and the proximal femoral nail
(PFN)) or a condylocephalic nail (for example, the Ender nail).
Types of outcome measures
The following outcomes were sought.
(1) Operative details
• length of surgery (in minutes)
• operative blood loss (in millilitres)
• number of patients transfused
• radiographic screening time (in seconds or minutes
(2) Fracture fixation complications
• operative fracture of the femur (around or below the
implant, but excluding comminution of the fracture site)
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• later fracture of the femur (around or below the implant)
• cut-out of the implant from the femoral head
• non-union of the fracture
• breakage of the implant
• all technical complications of fixation (sum of above six
outcomes with the addition of any other major complications of
fracture healing as specified in each study. Major complications
were defined as those which generally required revision surgery
or a change of surgical procedure during the primary operation,
such as using a longer nail. Excluded from this are minor
operative complications such as comminution of the fracture site
during surgery)
• other operative or fracture healing complications as detailed
in individual studies
• re-operation (within the follow-up period of the study)
• superficial wound infection
• deep wound infection (i.e. infection around the implant)
• wound haematoma/seroma
(3) Post-operative complications and hospital stay
• pressure sores
• pneumonia
• thromboembolic complications (deep vein thrombosis or
pulmonary embolism)
• any medical complication (as detailed in each individual
study, excluding wound infections)
• length of hospital stay (in days)
(4) Anatomical restoration
• leg shortening (preferably > 2 cm)
• varus deformity of the femoral neck
• external rotation deformity (preferably > 20 degrees)
(5) Final outcome measures
• mortality (within the follow-up period of the study)
• pain (persistent pain at the final follow-up assessment)
• mobility and use of walking aids
• failure to return to pre-fracture residential status
• functional activities of daily living
• composite function and hip scores
Data for any other outcomes as detailed in each individual study
were also considered for inclusion.
Search methods for identification of studies
Electronic searches
We searched the Cochrane Bone, Joint andMuscle Trauma Group
Specialised Register (June 2007), the Cochrane Central Register
of Controlled Trials (The Cochrane Library 2007, Issue 2), MED-
LINE (1966 to June week 3 2007) and EMBASE (1988 to 2007
Week 27). We searched the UK National Research Register (ac-
cessed June 2007) (http://www.update-software.com/National/
nrr-frame.html) andCurrentControlledTrials at www.controlled-
trials.com (accessed June 2007) for ongoing and recently com-
pleted trials. No language restriction was applied.
The general search strategies for hip fracture trials developed for
TheCochrane Library (Wiley InterScience),MEDLINE (2002 on-
wards) and EMBASE (2002 onwards) are shown in Appendix 1.
The hip fracture specificMEDLINE search was combined with all
three stages of the Cochrane optimal trial search strategy (Higgins
2005a).
Searching other resources
We searched reference lists of articles and our own reference
databases. We included the findings from handsearches of the
British Volume of the Journal of Bone and Joint Surgery sup-
plements (1996 onwards) and abstracts of the American Or-
thopaedic Trauma Association annual meetings (1996 to 2006:
http://www.hwbf.org/ota/am/) and American Academy of Or-
thopaedic Surgeons annualmeeting (2004 to2007: www.aaos.org/
wordhtml/libscip.htm). We also included handsearch results from
the final programmes of SICOT (1996 & 1999) and SICOT/
SIROT (2003), EFFORT (2007) and the British Orthopaedic As-
sociationCongress (2000, 2001, 2002, 2003, 2005 and 2006).We
scrutinised weekly downloads of “Fracture” articles in new issues
of 15 journals (Acta Orthop Scand; Am J Orthop; Arch Orthop
Trauma Surg; Clin J Sport Med; Clin Orthop; Foot Ankle Int;
Injury; J Am Acad Orthop Surg; J Arthroplasty; J Bone Joint Surg
Am; J Bone Joint Surg Br; J Foot Ankle Surg; J Orthop Trauma;
J Trauma; Orthopedics) from AMEDEO (www.amedeo.com).
Data collection and analysis
Selection of studies
We independently assessed potentially eligible trials for inclusion.
Titles of journals, names of authors or supporting institutionswere
not masked at any stage.
Data extraction and management
Using a data extraction form, we independently extracted data for
the outcomes listed above and resolved any differences by discus-
sion. We contacted all trialists for additional data and clarification
when necessary.
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Assessment of risk of bias in included studies
We assessed each trial independently, without masking, for its
quality of methodology and resolved any disagreement through
discussion. The main assessment was the method of randomisa-
tion, which is also separately graded A, B or C according to the
scheme within the Cochrane Handbook (Higgins 2005b). In to-
tal, we assessed 10 aspects of methodology (see Table 1). From the
first update (Issue 3, 2006) of the review, the scores of the indi-
vidual items were no longer summed.
Table 1. Methodological quality assessment scheme
Items Scores
1. Was there clear concealment of allocation? Score 3 (and code A) if allocation was concealed (e.g. numbered
sealed opaque envelopes drawn consecutively). Score 2 (and code
B) if there was a possible chance of disclosure before allocation.
Score 1 (and code B) if the method of allocation concealment or
randomisation was not stated or was unclear. Score 0 (and code C)
if allocation concealment was clearly not concealed such as those
trials using quasi-randomisation (e.g. even or odd date of birth).
2. Were the inclusion and exclusion criteria clearly defined? Score 1 if text states the type of fracture and which patients were
included and/or excluded. Otherwise score 0.
3. Were the outcomes of trial participants who withdrew or ex-
cluded after allocation described and included in an intention-to-
treat analysis?
Score 1 if yes or text states that no withdrawals occurred, or data
are presented that, by clearly showing ’participant flow’, allow this
to be inferred. Otherwise score 0.
4. Were the treatment and control groups adequately described at
entry and if so were the groups well matched or appropriate co-
variate adjustment made?
Score 1 if at least four admission details given (e.g. age, sex, mo-
bility, function score, mental test score, fracture type) with no
significant difference between groups or appropriate adjustment
made. Otherwise score 0.
5. Did the surgeons have experience of the operations they per-
formed in the trial, prior to its commencement?
Score 1 if text states there was an introductory period or that
surgeons were experienced. Otherwise score 0.
6. Were the care programmes other than trial options identical? Score 1 if text states they were or if this can be inferred. Otherwise
score 0.
7. Were the outcome measures clearly defined in the text with a
definition of any ambiguous terms encountered?
Score 1 if yes. Otherwise score 0.
8. Were the outcome assessors blind to assignment status? Score 1 if assessors of pain and function at follow up were blinded
to treatment outcome. Otherwise score 0.
9. Was the timing of outcome measures appropriate?A minimum
of six-months follow up for all surviving trial participants.
Score 1 if yes. Otherwise score 0.
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Table 1. Methodological quality assessment scheme (Continued)
10. Was loss to follow up reported and if so were less than five per
cent of trial participants lost to follow up?
Score 1 if yes. Otherwise score 0.
Measures of treatment effect
For each study, we calculated relative risks (RR) with 95% confi-
dence intervals for dichotomous outcomes, and mean differences
with 95% confidence intervals for continuous outcomes.
Assessment of heterogeneity
Both the chi² and I² tests (Higgins 2003) aswell as visual inspection
were used to determine whether heterogeneity was present and
whether data pooling was appropriate.
Data synthesis
Where appropriate, we pooled results of comparable groups of
trials using both the fixed-effect and random-effects models.
Sensitivity analysis
There were insufficient data to conduct our planned exploratory
sensitivity analyses based on allocation concealment and the re-
portage of surgical experience.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies; Characteristics of studies awaiting classification.
For this second update of this review, of four newly identified
studies, three (Efstathopoulos 2007, Starr 2006;Vidyadhara 2007)
were included and one (Suckel 2006) was excluded. Overall, a
total of 13 studies were considered, nine of which are included.
Three others are excluded for reasons given in the ’Characteristics
of excluded studies’. One study (Gahr 2003) remains in ’Studies
awaiting assessment’ pending the receipt of further information.
Eight included trials were reported in full in English language
journals. A full translation from Spanish was obtained for the
Marques 2005. Eight were single centre trials based in six dif-
ferent countries (Efstathopoulos 2007, Greece; Fritz 1999, Ger-
many;Hardy 2003, Belgium;Herrera2002, Spain;Marques 2005,
Spain; Papasimos 2005, Greece; Starr 2006, USA; Vidyadhara
2007, India). Schipper 2004 was a multicentre trial based in The
Netherlands. Papasimos 2005 tested three implants: those pa-
tients allocated to the sliding hip screw are included in a separate
Cochrane review (Parker 2008). Eight trials had predominantly
older populations, with mean ages ranging between 69 and 83
years. The exception was Starr 2006, which only included adults
under 50 years of age with high-energy fractures. Six trials (Fritz
1999; Hardy 2003; Schipper 2004; Marques 2005; Papasimos
2005; Vidyadhara 2007) included only patients with unstable
trochanteric proximal femoral fractures, whereas a minority of pa-
tients in the other three trials (Efstathopoulos 2007;Herrera 2002;
Starr 2006) had stable fractures. Further details of the nine in-
cluded studies are given in the ’Characteristics of included stud-
ies’. The trials tested five different comparisons between a number
of cephalocondylic nail designs. There were no trials evaluating
condylocephalic nails.
Proximal femoral nail (PFN) versus the Gamma nail
The PFNwas comparedwith the standardGammanail in 250 par-
ticipants in Herrera 2002, in 156 participants in Marques 2005,
in 80 participants in Papasimos 2005, and in 424 participants in
Schipper 2004.
ACE trochanteric nail versus the Gamma nail
The ACE trochanteric nail was compared with the trochanteric
Gamma nail in 112 participants in Efstathopoulos 2007, and with
the Gamma AP nail in 73 participants in Vidyadhara 2007.
’Gliding nail’ versus the Gamma nail
One trial (Fritz 1999) involving 80 participants compared the
gliding nail (where the lag screw of a Gamma nail is replaced with
a double T-shaped blade) with a standard Gamma nail.
Russell-Taylor Recon nail versus the long Gamma nail
One trial (Starr 2006) involving 34 participants compared the
Russell-Taylor Recon nail with the long Gamma nail.
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Dynamic versus static locked intramedullary nail
One trial (Hardy 2003) involving 81 participants compared a
modified intramedullary hip screw (IMHS) featuring a single slot-
ted hole that allowed dynamic locking of the nail versus the stan-
dard IMHS, which is locked distally with two screws.
Risk of bias in included studies
Three trials (Fritz 1999; Hardy 2003; Papasimos 2005) did not
specify their method of randomisation (item 1 of the scoring
scheme). Allocation concealment appeared very likely in Schipper
2004, which used numbered and blinded envelopes: the randomi-
sation sequence was computer-generated, stratified by participat-
ing centre and balanced in blocks of four and six patients. Both
Efstathopoulos 2007 and Starr 2006 used sealed envelopes, these
were reported to be numbered in Starr 2006. Vidyadhara 2007
used a computer-generated random numbers table. Herrera 2002
andMarques 2005were quasi-randomised: allocation in both trials
was based on odd and even record numbers. Fritz 1999, Marques
2005 Schipper 2004 and Starr 2006 reported that the surgeons in-
volved were experienced with the procedures under investigation
(item 5); the single surgeon in Vidyadhara 2007 also confirmed his
prior experience. There was no specific report of prior experience
of the surgeons with the implants being compared in the other
trials: the majority of operations were carried out by junior sur-
geons in Hardy 2003. Assessor blinding (item 8) does not appear
to have occurred in any of the trials. In Schipper 2004, follow up
was discontinued at four months for participants with complete
radiological consolidation; hence this trial scored zero for item 9
(timing of outcome measurement) despite the availability of one-
year follow-up data for the other participants of this trial.
The methodology assessment for the included studies rated ac-
cording to the system described earlier (see Table 1) are given be-
low:
1 2 3 4 5 6 7 8 9 10 Trial name
2 1 0 1 0 1 1 0 1 1 Efstathopoulos 2007
1 1 1 1 1 0 1 0 1 1 Fritz 1999
1 1 1 1 0 1 1 0 1 1 Hardy 2003
0 0 0 1 0 0 0 0 1 0 Herrera 2002
0 1 0 1 1 1 1 0 1 0 Marques 2005
1 1 0 0 0 1 1 0 1 0 Papasimos 2005
3 1 1 1 1 1 1 0 0 0 Schipper 2004
2 1 1 1 1 1 1 0 1 0 Starr 2006
1 1 1 1 1 1 1 0 1 1 Vidyadhara 2007
Effects of interventions
For this update, we were more successful in our attempts to obtain
further information from the contact investigators of these trials.
Previously, we received clarification of the method of randomi-
sation used in Herrera 2002. For this update, we received some
further details of methods and exact numbers of participants ex-
periencing key outcomes from Marques 2005; and confirmation
of the approach taken in the one-year analysis of Schipper 2004.
Proximal femoral nail (PFN) versus the Gamma nail
Four trials (Herrera 2002; Marques 2005; Papasimos 2005;
Schipper 2004) compared the PFNwith the standard Gamma nail
in a total of 910 participants. All participants had unstable frac-
tures other than 32 participants with stable fractures in Herrera
2002. Aside from Herrera 2002, which included 13 patients with
“neoplasia”, pathological fractures were excluded.
(1) Operative details
The mean length of surgery of the PFN group reported as be-
ing significantly shorter in Herrera 2002 (49 versus 68 minutes),
whereas it was reported to be significantly longer in Papasimos
2005 (71 versus 51 minutes). The mean length of surgery was 60
minutes in both groups of Schipper 2004.Marques 2005 reported
the difference between the two groups in the median length of
surgery (45 versus 40 minutes) was not statistically significant.
Schipper 2004 found intra-operative blood loss was statistically
significantly lower in the PFN group (mean difference -67.00 ml,
95% confidence interval (CI) -111.40 to -22.60 ml: see Analysis
1.1). Papasimos 2005 found the difference between the two groups
in mean operative blood loss (265 ml versus 250 ml) was not sta-
tistically significant. Though significantly more participants in the
PFN group of Herrera 2002 received blood transfusion, the con-
verse was true for Marques 2005 (see Analysis 1.2). These results
were not pooled since visual inspection of the transfusion results
from the two trials shows substantial heterogeneity (I² = 88.9%
when pooled).
Neither trial reporting radiographic screening time found a sta-
tistically significant difference in this outcome between the two
groups: for Marques 2005 the median times were 100 versus 120
seconds; for Papasimos 2005 the mean times were 0.26 minutes
in both groups.
(2) Fracture fixation complications
Operative details as presented by each study are summarised in
Analysis 1.3. None of the differences between the two groups in
the various aspects and intra-operative complications of fracture
fixation was statistically significant other than an increased risk
of greater trochanteric fractures, or intra-operative comminution
of the fracture around the trochanteric region, for those treated
with the Gamma nail (seeAnalysis 01.03.06, 6/165 versus 20/165;
RR 0.30, 95% CI 0.12 to 0.73). Herrera 2002 did not reveal the
surgical consequences of these fractures; both cases in Papasimos
2005 were treated conservatively. The difference between the two
groups in themore important outcome of operative fracture of the
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femurwas not statistically significant (seeAnalysis 01.03.07, 1/455
versus 5/455; RR 0.33, 95% CI 0.07 to 1.63). Marques 2005
attributed all three intraoperative femoral fractures to bad surgical
technique. The operative fracture in the Gamma nail group of
Papasimos 2005 was managed conservatively. In Schipper 2004
both operative fractures of the femur, featuring a subtrochanteric
extension, occurred in the Gamma nail group.
Analysis 1.4 presents the fracture healing complications as reported
by each study. None of the differences in outcomes between the
two implants in the pooled data from three or four studies was
statistically significant. The tendency to a higher rate of secondary
varus, reflecting a loss of reduction, in Herrera 2002 was stated
as not being linked with subsequent clinical problems. The most
common fracture healing complication was cut-out of the implant
(17/455 versus 24/455; RR 0.71, 95% CI 0.39 to 1.30). It should
be noted that in Schipper 2004, participants whose fractures were
judged to be healed at four months had no further radiological fol-
low up. There was no significant difference in the incidence of lo-
cal complications, which included cut-out, infection, haematoma,
migration of hip screws, malrotation, shaft fracture and nail fa-
tigue, at four months in Schipper 2004 (45/211 versus 47/213);
and similarly at 12 months (51/211 versus 50/213).
Pooled data from all four trials for reoperation showed no statis-
tically significant difference between the two groups (see Analysis
1.5, 45/455 versus 36/455; RR 1.25, 95%CI 0.83 to 1.90). There
were no significant differences between the two implants in any
of the reported wound complications (see Analysis 1.6).
(3) Post-operative complications and hospital stay
None of the differences between the two implant groups in spe-
cific post-operative complications were statistically significant in
Herrera 2002,Marques 2005 or Papasimos 2005 (seeAnalysis 1.7).
Schipper 2004 reported no difference between groups in medical
complications that had occurred by one-year follow up.
Herrera 2002 reported that trial participants remained in hospital
for an average of 14.1 days. Themean length of stay in hospital was
nearly a week longer in Schipper 2004; there being no significant
difference between the two groups (see Analysis 1.8). Similarly, the
difference between the two groups in the mean hospital stays were
reported to be not statistically significant for both Marques 2005
(mean hospital stay: 11.1 days for the PFN group versus 12.2 days
for the Gamma nail group) and Papasimos 2005 (8.6 days versus
8.8 days).
(4) Anatomical restoration
These outcomes were not reported in any of the trials. However,
two participants of the PFN group and one of the Gamma nail
group had reoperations for “rotational defect of the leg” inHerrera
2002.
(5) Final outcome measures
There was no statistically significant difference between the two
groups in mortality at 12 months for the three trials that provided
data (see Analysis 1.9, RR 1.08; 95% CI 0.82 to 1.41). Papasimos
2005 excluded from their analyses the data from the 10 people
who had died by one-year follow up.
The few functional outcome data that could be presented are
shown in Analysis 1.10 and Analysis 1.11. Data from Herrera
2002 showed no statistically significant difference between the two
groups in the failure to recover pre-fracture walking ability (RR
1.03; 95% CI 0.80 to 1.33). Pain in the thigh at follow up was
reported as being statistically significantly less in the PFN group
in Marques 2005 (4.7% versus 27.3%; reported P = 0.004) but
this difference was not apparent when the actual numbers of par-
ticipants with pain were obtained from the trialist (see Analysis
1.10). Marques 2005 reported there was no statistically signifi-
cant difference between the two groups in the final independent
mobility scores. Papasimos 2005 reported there was no significant
difference between the two groups in the return to pre-fracture
level of ambulation and independence. The Harris hip scores at
four weeks, six months and one year reported in Schipper 2004
showed no statistically significant difference between groups (see
Analysis 1.11); however, this was for a subgroup of patients at each
time point and thus may not be representative of the outcome for
the population of survivors.
ACE trochanteric nail versus Gamma nail
Two trials (Efstathopoulos 2007; Vidyadhara 2007) made this
comparison although with some variations in the intervention.
Efstathopoulos 2007 compared the ACE nail used with one prox-
imal screw versus the trochanteric Gamma nail in 112 people,
82% of whom had unstable fractures. In Vidyadhara 2007, the
ACE nail had two proximal screws and was compared with the AP
(Asian/pacific) Gamma nail in 73 people with unstable fractures.
Neither study included subtrochanteric fractures.
(1) Operative details
Efstathopoulos 2007 reported no difference in the mean length
of surgery between groups (see Analysis 2.1). Vidyadhara 2007
reported a higher median length of surgery for the ACE nail (43
versus 32minutes). The statistically significantly greater blood loss
found in Vidyadhara 2007 for the ACE nail is clinically minor
(see Analysis 2.1: mean difference 13 ml; 95% CI 6.78 to 19.22).
Efstathopoulos 2007 found no statistically significant differences
in the units of blood transfused, number of patients transfused
or the radiographic screening time (see Analysis 2.1 and Analysis
2.2).
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(2) Fracture fixation complications
There were no fracture healing complications reported in
Efstathopoulos 2007 and only one in Vidyadhara 2007 (see Anal-
ysis 2.3). This was a cut-out in the Gamma nail group that was
treated by removal of the implant followed by bed rest for three
months. Vidyadhara 2007 reported no wound infection whilst
Efstathopoulos 2007 reported four cases of superficial wound in-
fection in the ACE nail group versus three in the Gamma nail
group (see Analysis 2.4).
3) Post-operative complications and hospital stay
There were no significant differences between the two groups in
the limited data provided for post-operative complications (see
Analysis 2.5). Efstathopoulos 2007 reported similar mean lengths
of hospital stay for the two groups (7.2 versus 7.0 days; reported
as not significant).
(4) Anatomical restoration
Three people had limb shortening in Vidyadhara 2007, with no
significant differences between the two groups (see Analysis 2.6).
(5) Final outcome measures
There was no difference between the two groups in mortality
(seeAnalysis 2.7 ). Vidyadhara 2007 found no statistically signifi-
cant differences between the two groups in hip pain at one month
after injury, or the presence of a limp or difficulty in squatting at
two years (see Analysis 2.8). Efstathopoulos 2007 found no differ-
ence between the two groups in mobility scores at follow up (see
Analysis 2.9). Although the Harris hip scores at 4 months, one
year and two years were significantly different in the two groups
of Vidyadhara 2007, the very small differences were clinically in-
significant (see Analysis 2.10).
’Gliding nail’ versus the Gamma nail
Fritz 1999 compared the gliding nail (a modification of the
Gamma nail) with a standard Gamma nail. There were 40 partic-
ipants, all with an unstable trochanteric fracture, in each group.
(1) Operative details
Fritz 1999 reported there were no statistically significant differ-
ences between the two groups for length of surgery (mean dura-
tion: 63 versus 62 minutes) or operative blood loss (mean loss:
338 versus 296 ml).
(2) Fracture fixation complications
There were no statistically significant differences between the two
groups for these outcomes (see Analysis 3.1). There was one intra-
operative complication (a minor shaft fracture) in the gliding nail
group and seven intra-operative complications (six were due to
failed placement of the second locking screw) in the Gamma nail
group. One woman in the gliding nail group fell during mobilisa-
tion fracturing her femur shaft. Cut-out of the implant occurred
in three cases in the standard nail group. Reoperations (3 versus
4) resulted from these two complications, as well as from wound
infection and a haematoma.
(3) Post-operative complications and hospital stay
There were no statistically significant differences between the two
groups in those with any post-operative medical complication or
for specific complications as presented in Analysis 3.2. Fritz 1999
reported there was no statistically significant difference between
the two groups in the mean hospital stay (9.2 versus 10.4 days).
(4) Anatomical restoration
There were no statistically significant differences between the two
groups in those with leg shortening or rotational deformity (see
Analysis 3.3).
(5) Final outcome measures
No statistically significant difference was found between the two
groups for mortality (see Analysis 3.4), for residence of survivors
in a geriatric institution (see Analysis 3.5) or overall unfavourable
outcome, defined as residence in a geriatric institution or dead, at
six months. Fritz 1999 reported there were no statistically signif-
icant differences between the two groups in the Merle d’Aubigne
scores for pain, walking function, mobility or overall.
Russell-Taylor Recon nail versus long Gamma nail
Starr 2006 compared the Russell-Taylor Recon nail with the long
Gamma nail in 34 people, aged between 19 and 50 years, with
high energy extracapsular hip fracture. Five trial participants had
stable and 21 unstable trochanteric fractures, and the other eight
had subtrochanteric fractures. Three patients had open fractures
and 17 had concurrent surgery for other injuries.
(1) Operative details
Starr 2006 reported there were no statistically significant differ-
ences between the two groups for length of surgery (mean dura-
tion: 106 versus 88 minutes; reported P = 0.26) or operative blood
loss (mean loss: 328 versus 282 ml; reported P = 0.15).
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(2) Fracture fixation complications
There were no fracture fixation complications reported (see Anal-
ysis 4.1). One patient in the long Gamma nail group had wound
debridement for sepsis and a further 12 patients had elective re-
moval of their implants for persistent pain (see Analysis 4.1).
(3) Post-operative complications and hospital stay
These outcomes were not reported in Starr 2006.
(4) Anatomical restoration
These outcomes were not reported in Starr 2006.
(5) Final outcome measures
No deaths occurred within the one year follow-up period. Starr
2006 found no statistically significant differences between the two
groups in the numbers of participants who were unable to walk
independently or unable to return to the same work (see Analysis
4.2). The person who was unable to walk had sustained a spinal
cord injury at the time of her initial trauma. Similarly, there were
no statistically significant difference between the two groups in
the range of hip or knee movements. The Harris hip scores were
similar for the two groups (mean scores: 86 versus 84; reported P
= 0.60).
Dynamic versus static locked intramedullary nail
Hardy 2003 compared a dynamically locked intramedullary hip
screw (IMHS) which was allocated to 42 patients, with the usual
statically locked IMHS allocated to 39 patients.
(1) Operative details
There were no statistically significant differences between the two
groups for length of surgery, operative blood loss, haemoglobin
levels or transfusion requirements (see Analysis 5.1).
(2) Fracture fixation complications
There were no statistically significant differences between the two
groups for these outcomes (see Analysis 5.2). Cut-out of the im-
plant occurred in one case in the dynamic group and a fracture
below the tip in one case in the static group. Reoperations (1 ver-
sus 3) resulted from these two complications as well as from two
operations for hardware removal in the static group.
(3) Post-operative complications and hospital stay
Medical complications and length of hospital stay were not re-
ported in Hardy 2003. Though there were some discrepancies be-
tween text and tables in the trial report for discharge destination
and in-hospital deaths, there was clearly no difference between the
two groups in these outcomes.
(4) Anatomical restoration
Incomplete data for leg shortening (see Analysis 5.3) showed no
statistically significant difference between the two groups. (Subsi-
dence of the nail in the femoral shaft was seen in nine participants
of the dynamic group compared with none in the static group.)
No information on deformity was presented in Hardy 2003.
(5) Final outcome measures
No statistically significant difference was found between the two
groups for mortality (see Analysis 5.4). Pain in the mid-thigh re-
gion was reported at follow up for two participants of the dy-
namic group and six in the static group (see Analysis 5.5). The
pain impaired walking in four of the latter group. All six partic-
ipants reporting mid-thigh pain in the static group had cortical
hypertrophy. The other instance of cortical hypertrophy occurred
in a participant of the dynamic group who did not report mid-
thigh pain. Hardy 2003 reported similar results in the two groups
for accommodation, mobility scores and independence rating of
survivors at one year.
D I S C U S S I O N
The nine trials included in this review, involving a total of 1290
predominantly female and older people with predominantly un-
stable trochanteric fractures, tested five different comparisons. No
notable differences were found for each comparison either in the
individual trials or where data could be pooled. However, in each
case there were insufficient patient numbers to rule out important
differences. It is noteworthy that this review is predominantly a set
of comparisons of intramedullary nails from different manufac-
turers. Thus, it could be conjectured that it is primarily themarket
place that has set the research agenda and associated aims of these
underpowered trials. Comments on each of the comparisons are
provided below.
Proximal femoral nail (PFN) versus the Gamma
nail
Herrera 2002 was a quasi-randomised trial whose report did not
provide a satisfactory account of trial methods, particularly to con-
firm intention-to-treat analysis. Marques 2005 was also a quasi-
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randomised trial. The inconsistencies between the percentages pre-
sented in the trial report and the data received subsequently for
Marques 2005 show the importance of presenting a participant
flow diagram, as done by Schipper 2004. A participant flow dia-
gram would also have helped in Papasimos 2005, where the base-
line and early outcome results were not provided for 21 partici-
pants. Particular caution is required on viewing the results of these
two trials. While Schipper 2004 recruited 424 patients, their de-
cision to only follow up trial participants with non-consolidated
fractures after four months considerably reduced the numbers
available at one year.
The only statistically significant difference arising from pooled
datawas an increased risk of greater trochanteric fractures, or intra-
operative comminution of the fracture around the trochanteric re-
gion, for those treatedwith theGammanail (seeAnalysis 01.03.06,
6/165 versus 20/165; RR 0.30, 95% CI 0.12 to 0.73). This re-
sult is dominated by the results of Herrera 2002 (5/125 versus
19/125), which did not reveal the surgical consequences of these
fractures. It is likely that these were of no clinical significance. Both
cases in Papasimos 2005 were treated conservatively. The differ-
ence between the two groups in the more important outcome of
operative fracture of the femur was not statistically significant (RR
0.33, 95% CI 0.07 to 1.63).
Schipper 2004 acknowledged the high revision rates, for both im-
plants, in their study but stressed their inclusion of exclusively
unstable fractures. Indeed their reoperation rate (9.2% at four
months; 11.8% at one year) is high, and it is notable that it is
markedly higher than that (5.4%) reported for short femoral nails
or, indeed, the SHS (3.4%) (Parker 2008). At 10%, the overall
reoperation rate for Papasimos 2005 was also high. The overall
reoperation rate for Herrera 2002 was 6.0%; excluding stable frac-
tures it was 6.8%. For Marques 2005, the reoperation rate was
5.1%.
ACE trochanteric nail versus Gamma nail
The two studies addressing this comparison used different im-
plants or techniques and had different populations. The only frac-
ture fixation complication reported was a cut-out which resulted
in a re-operation in Vidyadhara 2007. The outcome of this trial,
which had no deaths or loss to follow up, was otherwise very
favourable for both groups as shown by the usually high Harris
hip scores with very little variation within each group. Supposing
that the correct statistics were presented, the clinical significance
of the statistically significant differences in blood loss and Harris
hip scores is questionable in Vidyadhara 2007. Coupled with the
other findings of no differences between the implants in these two
small trials, no definite conclusions can be drawn on the relative
effectiveness of the two implants.
’Gliding nail’ versus the Gamma nail
The gliding nail was designed to avoid the complications of im-
plants such as the Gamma nail by virtue of an enlarged surface
area for load transmission and a higher stability. Whilst cut-out of
the implant was less in the gliding nail group (3/40 versus 0/40),
no definite conclusions can be drawn from this study on whether
the gliding nail actually reduces the risk of fixation complications
relative to the Gamma nail due the limited number of study par-
ticipants.
Russell-Taylor Recon nail versus long Gamma
nail
The single study included people with high energy fractures aged
between 18 and 50 years; 17 of whom had concurrent surgery for
other injuries. Thus, this was a very different population to the
other trials in this review. There was a high rate of elective removal
of implants for pain compared with the other trials. Though Starr
2006 found no notable differences in outcomes or complications
between the two implants it is too small to conclude this is a true
finding.
Dynamic versus static locked intramedullary nail
Though none of the differences between the two groups reached
statistical significance, Hardy 2003 suggested that lower incidence
of cortical hypertrophy of the bone at the level of the distal locking
screws in the dynamic group was linked with the lower number of
participants with mid-thigh pain in the dynamic group. However,
though this suggestion is plausible, the limited number of study
participants mean that no firm conclusions can be made regarding
the effects of dynamic compared with static locking of the IMHS.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
There was insufficient evidence from randomised trials to deter-
mine if there are important differences in patient outcomes be-
tween the different designs of proximal femoral intramedullary
nail produced by different manufacturers when used for the fixa-
tion of unstable trochanteric fractures.
Implications for research
Given the evidence indicating the current superiority of the slid-
ing hip screw (SHS) over intramedullary nails for trochanteric
fractures (Parker 2008), it is debatable whether studies comparing
different types or aspects of intramedullary nails design should be
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undertaken. Nonetheless, while we suggest that further develop-
ment and modification of cephalocondylic nails for these fractures
is not a priority, any new developments should be evaluated using
robust methodology with adequate patient numbers. We suggest
the choice of comparator of any such trial should be the SHS.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Efstathopoulos 2007
Methods Randomised trial: sealed envelopes
Length of follow up: mean 8 months (range 6 to 12 months)
Participants Orthopaedic hospital, Athens, Greece
112 people aged 65 or over with a trochanteric proximal femoral fracture (Jensen types I and II : stable
(18%), or III and IV: unstable (82%))
Age: mean 78 years (range 69 to 89 years)
% male: 29%
Number lost to follow up: 5 (4.5%)
Assigned: 56/56 [ACE trochanteric nail / trochanteric Gamma nail]
Interventions ACE trochanteric nail versus a trochanteric Gamma nail.
The ACE nail was 11 mm diameter, inserted without reaming and with one proximal screw and one
distally locking screw. The Gamma nail was 11 mm distal diameter, and inserted with reaming and had
one distal locking screw.
Outcomes Length of surgery
Units of blood transfused
Number of patients transfused
Radiographic screening time
Cut-out of implant
Operative fracture of femur
Later fracture of the femur
Non-union
Reoperation
Wound infection
Deep wound infection
Deep vein thrombosis
All medical complications
Length of hospital stay
Mortality
Mobility
Notes The trial report clearly states that there were no fracture healing complications: the outcome of no
reoperations was inferred from this.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Fritz 1999
Methods Randomised trial: method not stated except that it was “non-stratified”
Length of follow up: 6 months
Participants Orthopaedic hospital, Heidelberg, Germany
80 people with an unstable trochanteric proximal femoral fracture
Age: mean 83 years
% male: 14%
Number lost to follow up: 1 (1.3%)
Assigned: 40/40 [Gliding nail / Gamma nail]
Interventions Gliding nail (125 degree) versus a standard (130 degree) Gamma nail.
For the gliding nail, the lag screw of the standard Gamma nail was replaced by a double T profile blade.
All nails were 220 mm long and 12 mm in diameter. A double distal locking was aimed for in all cases.
Outcomes Length of surgery
Operative blood loss
Operative fracture
Cut-out of implant
Later fracture of the femur
Reoperation
Medical complications
Pneumonia
Cerebrovascular accident
Decubitus ulcers
Length of hospital stay
Limb shortening
Rotational deformity
Mortality
Residence
Mobility
Pain
Function: Merle d’ Aubigne score
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Hardy 2003
Methods Randomised trial: method not stated
Length of follow up: mean 37 months (range 12 to 49 months)
Participants Orthopaedic hospital, Brussels, Belgium
81 people with an unstable trochanteric proximal femoral fracture (fracture types featuring loss of medial
support: Jensen types IV and V; or reversed oblique fracture lines)
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Hardy 2003 (Continued)
Age: mean 77 years
% male: 38%
Number lost to follow up: 1 (1.3%)
Assigned: 42/39 [Dynamic / Static locking]
Interventions Intramedullary hip screw (IMHS) with a slotted hole to allow for dynamic distal locking of the nail with
one screw versus a standard IMHS statically locked with two distal locking screws.
All nails were 12 mm in diameter, with a 135 degree angle between the nail and lag screw, and 4 degree
valgus angle.
Outcomes Length of surgery
Operative blood loss
Haemoglobin level
Volume of blood transfused
Cut-out of implant
Later fracture of the femur
Reoperation
Mortality
Pain
Mobility score
Independence (Jensen’s autonomy index)
Limb shortening
Subsidence of the nail
Cortical hypertrophy
Notes One patient allocated dynamic locking was excluded because the nail was erroneously locked with two
screws.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Herrera 2002
Methods Quasi-randomised trial: based on odd and even record numbers
Length of follow up: 12 months minimum
Participants Orthopaedic hospital, Zaragoza, Spain
250 people with a trochanteric proximal femoral fracture: A1, A2 or A3 (stable and unstable). Pathological
fractures included
Age: mean 79 years
% male: 28%
Number lost to follow up: not stated
Assigned: 125/125 [PFN / Gamma nail]
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Herrera 2002 (Continued)
Interventions Proximal femoral nail (PFN): usually 130 degree, 10 mm (inserted without reaming) versus a Gamma
nail (usually a 130 degree, 11 mm) inserted with reaming.
With 3 exceptions (in the Gamma nail group) nails were locked distally using one or two screws.
Outcomes Length of surgery
Operative blood loss
Blood transfusion
Cut-out of implant
Operative fracture of femur (greater trochanter)
Later fracture of the femur
Secondary varus (>10%)
Breakage of implant
Poor reduction of fracture
Migration of the proximal nail screw(s)
Non-union (and time to healing)
Reoperation
Seroma
Haematoma
Superficial wound infection
Deep wound infection
Length of hospital stay
Pressure sores
Pulmonary embolism
Acute post-operative confusion
Digestive haemorrhage
Acute kidney failure
Muscle pain “due to point effect”
Mortality
Recovery of walking ability
Notes Information on method of randomisation received from Dr Herrera (28/09/04)
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No C - Inadequate
Marques 2005
Methods Quasi-randomised trial: based on odd and even record numbers
Length of follow up: 12 months
Participants Orthopaedic hospital, Barcelona, Spain
156 people with an unstable trochanteric proximal femoral fracture (AO types 31 A2 and A3)
Age: mean 82 years
% male: 24%
Number lost to follow up: 25 (16%)
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Marques 2005 (Continued)
Assigned: 79/77 [PFN / Gamma nail]
Interventions Proximal femoral nail (PFN) versus a trochanteric Gamma nail.
The PFN was 10 mm diameter, inserted without reaming, and had two distally locking screws. The
Gamma nail was 11 mm distal diameter, and inserted with reaming and had one distal locking screw.
With 3 exceptions (in the Gamma nail group) nails were locked distally using one or two screws.
Outcomes Length of surgery
Haemoglobin level
Number of patients transfused
Radiographic screening time
Cut-out of implant
Operative fracture of femur
Later fracture of the femur
Reoperation
Haematoma
Deep wound infection
Length of hospital stay
Pressure sores
Pulmonary embolism
Deep vein thrombosis
Pneumonia
Mortality
Pain in thigh
Notes Additional information supplied by Dr Marques included exact numbers of people with key outcomes.
It should be noted, however, that the percentages given in the paper are generally inconsistent with the
data provided by Dr Marques.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No C - Inadequate
Papasimos 2005
Methods Randomised trial: method not stated
Length of follow up: mean 12 months
Participants Orthopaedic hospital, Patras Hellas, Greece
141 people with an unstable trochanteric proximal femoral fracture (see Notes)
Age (of 80 participants): mean 81 years
% male (of 80): 41%
Number lost to follow up (of 141): 11 (7.8%)
Assigned: ?/? [PFN / Gamma nail]
In analyses: 40/40 [PFN / Gamma nail]
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Papasimos 2005 (Continued)
Interventions Proximal femoral nail (PFN) versus a trochanteric Gamma nail.
11 or 12 mm diameter PFN with distal locking in 37 out of 40 participants. 135 degree trochanteric
Gamma nail with 17 mm proximal diameter and 11 mm distal diameter and distal locking in all partici-
pants.
Outcomes Length of surgery
Operative blood loss
Radiographic screening time
Operative fracture (some of greater trochanter)
Cut-out of implant
Later fracture of the femur
Non-union
Reoperation
Superficial wound infection
Haematoma
Medical complications
Chest infection
Pneumonia
Mental disturbances
Deep vein thrombosis
Pulmonary embolism
Urinary infection
Length of hospital stay
Time to fracture consolidation
Function: Salvati and Wilson score
Notes There were 141 people randomised into this trial but the intervention groups for the 10 participants who
died before one year and the 11whowere lost to follow upwere not identified. Forty of the 120 participants
included in the trial analyses were treated with a sliding hip screw. The results for this group are included
in the Cochrane review ’Gamma and other cephalocondylic intramedullary nails versus extramedullary
implants for extracapsular hip fractures in adults’.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Schipper 2004
Methods Randomised trial: numbered and blinded envelopes with computer generated randomisation code
Length of follow up: 4 months for whole trial population; 12 months for those with non-consolidated
fractures at 4 months
Participants Multi-centre study conducted in 9 orthopaedic hospitals, The Netherlands
424 people with an unstable trochanteric proximal femoral fracture. Age 60 or above
Age: mean 82 years
% male: 18%
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Schipper 2004 (Continued)
Number lost to follow up: 12 at 4 months (2.8%)
Assigned: 211/213 [PFN / Gamma nail]
Interventions Proximal femoral nail (PFN) versus a standard (130 degree,11 mm) mark 3 Gamma nail.
The PFN was 130 degree, 10 or 11 mm, and inserted without reaming. The Gamma nail was inserted
with reaming.
All nails were locked distally in a static mode.
Outcomes Length of surgery
Operative blood loss
Cut-out of implant
Operative fracture of femur
Later fracture of the femur
Technical difficulty during surgery
Breakage of implant
Suboptimal screw position
Malrotation
Need of open reduction
Poor reduction of fracture
Migration of the proximal nail screw(s)
Union (fracture consolidation)
Reoperation
Superficial wound infection
Deep wound infection
Time to full weight bearing
Length of hospital stay
Pressure sores
Pneumonia
Thromboembolic complications
Cardiovascular, urogenital, neurological, gastrointestinal and psychiatric complications
Mortality
Harris Hip Surgery score
Notes Follow up of the full trial population was up to 4 months. As per protocol, only those with incomplete
radiological consolidation of their fractures at 4 months (85 versus 83) were followed up until 12 months.
Additional clarification on results supplied by trialists.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
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Starr 2006
Methods Randomised trial: numbered sealed envelopes (some attempt made to obscure allocation but of uncertain
effectiveness)
Length of follow up: minimum 12 months (range 12 to 29 months)
Participants Orthopaedic hospital, Dallas, USA
34 people (aged 10 to 50 years) with an extracapsular proximal femoral fracture caused by high energy
trauma (15% stable trochanteric, 62% unstable trochanteric, 24% subtrochanteric fractures)
Age: mean 34 years (range 19 to 50 years)
% male: 35%
Number lost to follow up: 6 (18%)
Assigned: 17/17 [Russell Taylor / long Gamma nail]
Interventions Russell Taylor Recon or Delta Intramedullary nail versus a long Gamma intramedullary nail.
The Russell Taylor nails were 10-14 mm distal diameter and had two proximal screws. The Gamma nails
were 11 mm distal diameter. All nails were statically locked.
Outcomes Length of surgery
Operative blood loss
Cut-out of implant
Operative fracture of the femur
Later fracture of the femur
Non-union
Reoperation
Wound infection
Deep would infection
Mortality
Harris hip score
Mobility
Unable to do the same work
Hip and knee range of movement
Notes Extra information including method of randomisation and fracture distribution was supplied by trialists.
Three patients had open fractures and 17 (9 versus 8) had concurrent surgery for other injuries.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Vidyadhara 2007
Methods Randomised trial: computer generated random numbers table
Length of follow up: 24 months
Participants Orthopaedic hospital, Karnataka, India
73 people with an unstable trochanteric proximal femoral fracture (AO types 31 A2.2, A2.3, A3.1, A3.2
and A3.3)
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Vidyadhara 2007 (Continued)
Age: mean 69 years (range 61 to 89 years)
% male: 51%
Number lost to follow up: none
Assigned: 36/37 [ACE trochanteric nail / AP Gamma nail]
Interventions ACE trochanteric nail versus an AP (Asian/Pacific) Gamma nail.
Nails of 130 degree angle and 200 mm length used in both groups. Both nails locked distally with the
upper screw. The proximal anti-rotation screw was used in all cases of the ACE nail.
Outcomes Length of surgery
Operative blood loss
Cut-out of implant
Later fracture of the femur
Non-union
Reoperation
All wound infection
Deep wound infection
Deep vein thrombosis
Shortening
Pain (at 1 month)
Mortality
Harris hip score
Mobility
Limp
Difficulty in squatting
Notes Extra information, including no loss to follow up or deaths, supplied by trialists
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
PFN: proximal femoral nail
Characteristics of excluded studies [ordered by study ID]
Merenyi 1995 This conference abstract suggested a randomised trial comparing three “different types of Gamma nail” versus Ender
nails versus angle plates. Previous correspondence with the authors indicated there was no randomisation of patients
only a ’random’ selection of patients which had been previously treated with one of the different types of implant.
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(Continued)
Suckel 2006 This was a comparative study of 240 patients with extra-articular femur fractures: 124 were treated with a proximal
femoral nail and 116 with a gliding nail. The study was excluded as there was no randomisation of patients.
Wagner 1998 Translation fromGerman of themethods of this comparative study of the intramedullary hip screw with the Gamma
nail established that it was not a randomised trial.
Characteristics of studies awaiting assessment [ordered by study ID]
Gahr 2003
Methods Quasi-randomised trial: alternation
Participants 50 participants with a proximal femoral fracture
Interventions Long Gamma nail 10 mm diameter versus long Gamma nail 11 mm diameter
Outcomes X-ray time; length of surgery; need for reaming femur; fixation complications: one cut-out in the 10 mm group
Notes Trial report in German with English abstract for outcomes until hospital discharge (mean 19 days). Follow up is
incomplete but no further report identified. No response from contact author (latest: March 2006).
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D A T A A N D A N A L Y S E S
Comparison 1. Proximal femoral nail (PFN) versus Gamma nail
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Operative details: length of
surgery and blood loss
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
1.1 Length of surgery
(minutes)
1 Mean Difference (IV, Fixed, 95% CI) Not estimable
1.2 Blood loss (ml) 1 Mean Difference (IV, Fixed, 95% CI) Not estimable
2 Number of patients transfused 2 Risk Ratio (M-H, Random, 95% CI) Totals not selected
3 Intra-operative complications 4 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
3.1 Changed method of
fixation
1 424 Risk Ratio (M-H, Fixed, 95% CI) 0.76 [0.17, 3.34]
3.2 Open reduction 1 424 Risk Ratio (M-H, Fixed, 95% CI) 2.15 [0.95, 4.86]
3.3 Poor reduction 2 504 Risk Ratio (M-H, Fixed, 95% CI) 2.01 [0.62, 6.57]
3.4 Difficult surgery 2 504 Risk Ratio (M-H, Fixed, 95% CI) 1.46 [0.98, 2.19]
3.5 Difficult proximal or distal
screw insertion
1 424 Risk Ratio (M-H, Fixed, 95% CI) 1.01 [0.36, 2.83]
3.6 Intra-operative
comminution of the fracture
around the trochanteric region
2 330 Risk Ratio (M-H, Fixed, 95% CI) 0.3 [0.12, 0.73]
3.7 Operative fracture of the
femur
4 910 Risk Ratio (M-H, Fixed, 95% CI) 0.33 [0.07, 1.63]
3.8 Suboptimal position of
fixation devices
1 424 Risk Ratio (M-H, Fixed, 95% CI) 1.23 [0.77, 1.95]
4 Fracture healing complications 4 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
4.1 Cut-out 4 910 Risk Ratio (M-H, Fixed, 95% CI) 0.71 [0.39, 1.30]
4.2 Later fracture of femur 4 910 Risk Ratio (M-H, Fixed, 95% CI) 0.82 [0.24, 2.84]
4.3 Implant breakage 3 754 Risk Ratio (M-H, Fixed, 95% CI) 0.34 [0.01, 8.21]
4.4 Non-union/
pseudoarthrosis
3 754 Risk Ratio (M-H, Fixed, 95% CI) 0.60 [0.14, 2.50]
4.5 Secondary varus (> 10%) 1 250 Risk Ratio (M-H, Fixed, 95% CI) 4.5 [0.99, 20.41]
4.6 Fracture site collapse due
to screw migration
1 250 Risk Ratio (M-H, Fixed, 95% CI) 2.5 [0.81, 7.76]
4.7 Medial or lateral hip screw
migration
1 424 Risk Ratio (M-H, Fixed, 95% CI) 6.06 [1.37, 26.74]
4.8 Muscle pain due to ’point
effect’
1 250 Risk Ratio (M-H, Fixed, 95% CI) 0.57 [0.17, 1.90]
5 Reoperation 4 910 Risk Ratio (M-H, Fixed, 95% CI) 1.25 [0.83, 1.90]
6 Wound complications 4 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
6.1 Seroma 1 250 Risk Ratio (M-H, Fixed, 95% CI) 0.90 [0.51, 1.60]
6.2 Haematoma 4 910 Risk Ratio (M-H, Fixed, 95% CI) 0.97 [0.62, 1.51]
6.3 Superficial infection 3 754 Risk Ratio (M-H, Fixed, 95% CI) 0.65 [0.32, 1.29]
6.4 Deep infection 3 830 Risk Ratio (M-H, Fixed, 95% CI) 1.01 [0.34, 2.95]
7 Post-operative complications 3 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
7.1 Pneumonia 2 236 Risk Ratio (M-H, Fixed, 95% CI) 2.93 [0.12, 70.72]
7.2 Pressure sores 2 406 Risk Ratio (M-H, Fixed, 95% CI) 1.08 [0.51, 2.30]
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7.3 Deep vein thrombosis 2 236 Risk Ratio (M-H, Fixed, 95% CI) 1.65 [0.22, 12.29]
7.4 Pulmonary embolism 3 486 Risk Ratio (M-H, Fixed, 95% CI) 1.5 [0.25, 8.85]
7.5 Acute post-operative
mental confusion
2 330 Risk Ratio (M-H, Fixed, 95% CI) 0.78 [0.44, 1.39]
7.6 Urinary infection 2 330 Risk Ratio (M-H, Fixed, 95% CI) 1.13 [0.44, 2.84]
7.7 Digestive haemorrhage 1 250 Risk Ratio (M-H, Fixed, 95% CI) 0.33 [0.01, 8.10]
7.8 Acute kidney failure 1 250 Risk Ratio (M-H, Fixed, 95% CI) 0.5 [0.05, 5.44]
8 Length of hospital stay (days) 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
9 Mortality 3 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
9.1 At 4 months 1 424 Risk Ratio (M-H, Fixed, 95% CI) 1.27 [0.82, 1.96]
9.2 At 12 months 3 830 Risk Ratio (M-H, Fixed, 95% CI) 1.08 [0.82, 1.41]
10 Final functional outcomes 3 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
10.1 Pain at follow up 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
10.2 Symptoms or restriction
from the hip
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
10.3 Incomplete recovery
of walking ability (including
death)
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
11 Harris hip scores (0 to 100:
high values = best function)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
11.1 At 4 weeks 1 Mean Difference (IV, Fixed, 95% CI) Not estimable
11.2 At 4 months 1 Mean Difference (IV, Fixed, 95% CI) Not estimable
11.3 At 1 year 1 Mean Difference (IV, Fixed, 95% CI) Not estimable
Comparison 2. ACE trochanteric nail versus Gamma nail
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Operative details: length
of surgery, blood loss and
radiographic screening time
2 Mean Difference (IV, Fixed, 95% CI) Totals not selected
1.1 Length of surgery
(minutes)
1 Mean Difference (IV, Fixed, 95% CI) Not estimable
1.2 Operative blood loss (mls) 1 Mean Difference (IV, Fixed, 95% CI) Not estimable
1.3 Units of blood transfused 1 Mean Difference (IV, Fixed, 95% CI) Not estimable
1.4 Radiographic screening
time (minutes)
1 Mean Difference (IV, Fixed, 95% CI) Not estimable
2 Number of patients transfused 1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
3 Fracture healing complications 2 Odds Ratio (M-H, Fixed, 95% CI) Subtotals only
3.1 Operative fracture of
femur
2 185 Odds Ratio (M-H, Fixed, 95% CI) Not estimable
3.2 Later fracture of femur 2 185 Odds Ratio (M-H, Fixed, 95% CI) Not estimable
3.3 Cut-out 2 185 Odds Ratio (M-H, Fixed, 95% CI) 0.33 [0.01, 8.45]
3.4 Non-union 2 185 Odds Ratio (M-H, Fixed, 95% CI) Not estimable
3.5 All fracture healing
complications
2 185 Odds Ratio (M-H, Fixed, 95% CI) 0.33 [0.01, 8.45]
3.6 Reoperation 2 185 Odds Ratio (M-H, Fixed, 95% CI) 0.33 [0.01, 8.45]
4 Wound complications 2 Odds Ratio (M-H, Fixed, 95% CI) Subtotals only
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4.1 All wound infection 2 185 Odds Ratio (M-H, Fixed, 95% CI) 1.36 [0.29, 6.37]
4.2 Deep wound infection 2 185 Odds Ratio (M-H, Fixed, 95% CI) Not estimable
5 Post-operative complications 2 Odds Ratio (M-H, Fixed, 95% CI) Subtotals only
5.1 Deep vein thrombosis 2 185 Odds Ratio (M-H, Fixed, 95% CI) 0.33 [0.01, 8.21]
5.2 All medical complications 1 88 Odds Ratio (M-H, Fixed, 95% CI) 1.37 [0.56, 3.36]
6 Anatomical restoration 1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
6.1 Shortening (1 cm or more) 1 Odds Ratio (M-H, Fixed, 95% CI) Not estimable
7 Mortality 2 185 Odds Ratio (M-H, Fixed, 95% CI) 1.0 [0.14, 7.36]
8 Final functional outcomes 1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
8.1 Hip pain at 1 month 1 Odds Ratio (M-H, Fixed, 95% CI) Not estimable
8.2 Limp 1 Odds Ratio (M-H, Fixed, 95% CI) Not estimable
8.3 Difficulty in squatting 1 Odds Ratio (M-H, Fixed, 95% CI) Not estimable
9 Mobility score (0: no difficulties
to 9: most difficulties)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
10 Harris hip scores (0 to 100:
high values = best function)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
10.1 At 4 months 1 Mean Difference (IV, Fixed, 95% CI) Not estimable
10.2 At 1 year 1 Mean Difference (IV, Fixed, 95% CI) Not estimable
10.3 At 2 years 1 Mean Difference (IV, Fixed, 95% CI) Not estimable
Comparison 3. Gliding nail versus Gamma nail
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Fracture fixation complications 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
1.1 Operative fracture of
femur
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
1.2 Later fracture of femur 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
1.3 Cut-out 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
1.4 Technical complications
of fixation
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
1.5 Reoperation 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
2 Post-operative complications 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
2.1 Participants with a
complication
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
2.2 Pressure sores (decubitus) 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
2.3 Pneumonia 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
2.4 Cerebrovascular accident 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
2.5 Apoplexy 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
2.6 Forearm fracture 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
3 Anatomical deformity 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
3.1 Leg shortening > 2 cm 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
3.2 External rotation > 20
degrees
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
3.3 Internal rotation > 20
degrees
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
4 Mortality at 6 months 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
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5 Residence and unfavourable
outcome (geriatric institution
or death) at 6 months
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
5.1 Living in an geriatric
institution
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
5.2 Unfavourable outcome
(institutionalised or dead)
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
Comparison 4. Russell-Taylor Recon nail versus long Gamma nail
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Fracture healing and wound
healing complications
1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
1.1 Operative fracture of
femur
1 Odds Ratio (M-H, Fixed, 95% CI) Not estimable
1.2 Later fracture of femur 1 Odds Ratio (M-H, Fixed, 95% CI) Not estimable
1.3 Cut-out 1 Odds Ratio (M-H, Fixed, 95% CI) Not estimable
1.4 Non-union 1 Odds Ratio (M-H, Fixed, 95% CI) Not estimable
1.5 All fracture healing
complications
1 Odds Ratio (M-H, Fixed, 95% CI) Not estimable
1.6 Wound infection (any
type)
1 Odds Ratio (M-H, Fixed, 95% CI) Not estimable
1.7 Deep wound infection 1 Odds Ratio (M-H, Fixed, 95% CI) Not estimable
1.8 Reoperation 1 Odds Ratio (M-H, Fixed, 95% CI) Not estimable
2 Final outcome measures 1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
2.1 Mortality 1 Odds Ratio (M-H, Fixed, 95% CI) Not estimable
2.2 Non-independent
ambulator
1 Odds Ratio (M-H, Fixed, 95% CI) Not estimable
2.3 Unable to do the same
work
1 Odds Ratio (M-H, Fixed, 95% CI) Not estimable
Comparison 5. Dynamic versus static locked intramedullary nail
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Operative details 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
1.1 Length of surgery
(minutes)
1 Mean Difference (IV, Fixed, 95% CI) Not estimable
1.2 Intra-operative blood loss
(minutes)
1 Mean Difference (IV, Fixed, 95% CI) Not estimable
1.3 Haemoglobin level: 48
hours post-op (g/dL)
1 Mean Difference (IV, Fixed, 95% CI) Not estimable
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1.4 Transfused packed blood
cells
1 Mean Difference (IV, Fixed, 95% CI) Not estimable
2 Fracture fixation complications 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
2.1 Later fracture of the femur 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
2.2 Cut-out 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
2.3 Technical complications
of fixation
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
2.4 Reoperation 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
3 Leg shortening (mm) in those
able to undergo a radiographic
assessment
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
4 Mortality at 1 year 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
5 Pain and cortical hypertrophy 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
5.1 Mid-thigh pain 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
5.2 Cortical hypertrophy 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
Analysis 1.1. Comparison 1 Proximal femoral nail (PFN) versus Gamma nail, Outcome 1 Operative details:
length of surgery and blood loss.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 1 Proximal femoral nail (PFN) versus Gamma nail
Outcome: 1 Operative details: length of surgery and blood loss
Study or subgroup PFN Gamma nail Mean Difference Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Length of surgery (minutes)
Schipper 2004 211 60 (29.05) 213 60 (29.19) 0.0 [ -5.54, 5.54 ]
2 Blood loss (ml)
Schipper 2004 211 220 (199.84) 213 287 (262.7) -67.00 [ -111.40, -22.60 ]
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Analysis 1.2. Comparison 1 Proximal femoral nail (PFN) versus Gamma nail, Outcome 2 Number of
patients transfused.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 1 Proximal femoral nail (PFN) versus Gamma nail
Outcome: 2 Number of patients transfused
Study or subgroup PFN Gamma nail Risk Ratio Risk Ratio
n/N n/N M-H,Random,95% CI M-H,Random,95% CI
Herrera 2002 65/125 47/125 1.38 [ 1.04, 1.83 ]
Marques 2005 29/79 41/77 0.69 [ 0.48, 0.99 ]
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Analysis 1.3. Comparison 1 Proximal femoral nail (PFN) versus Gamma nail, Outcome 3 Intra-operative
complications.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 1 Proximal femoral nail (PFN) versus Gamma nail
Outcome: 3 Intra-operative complications
Study or subgroup PFN Gamma nail Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Changed method of fixation
Schipper 2004 3/211 4/213 0.76 [ 0.17, 3.34 ]
Subtotal (95% CI) 211 213 0.76 [ 0.17, 3.34 ]
Total events: 3 (PFN), 4 (Gamma nail)
Heterogeneity: not applicable
Test for overall effect: Z = 0.37 (P = 0.71)
2 Open reduction
Schipper 2004 17/211 8/213 2.15 [ 0.95, 4.86 ]
Subtotal (95% CI) 211 213 2.15 [ 0.95, 4.86 ]
Total events: 17 (PFN), 8 (Gamma nail)
Heterogeneity: not applicable
Test for overall effect: Z = 1.83 (P = 0.068)
3 Poor reduction
Papasimos 2005 2/40 2/40 1.00 [ 0.15, 6.76 ]
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Study or subgroup PFN Gamma nail Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Schipper 2004 6/211 2/213 3.03 [ 0.62, 14.83 ]
Subtotal (95% CI) 251 253 2.01 [ 0.62, 6.57 ]
Total events: 8 (PFN), 4 (Gamma nail)
Heterogeneity: Chi2 = 0.77, df = 1 (P = 0.38); I2 =0.0%
Test for overall effect: Z = 1.16 (P = 0.25)
4 Difficult surgery
Papasimos 2005 14/40 9/40 1.56 [ 0.76, 3.18 ]
Schipper 2004 34/211 24/213 1.43 [ 0.88, 2.33 ]
Subtotal (95% CI) 251 253 1.46 [ 0.98, 2.19 ]
Total events: 48 (PFN), 33 (Gamma nail)
Heterogeneity: Chi2 = 0.04, df = 1 (P = 0.85); I2 =0.0%
Test for overall effect: Z = 1.85 (P = 0.064)
5 Difficult proximal or distal screw insertion
Schipper 2004 7/211 7/213 1.01 [ 0.36, 2.83 ]
Subtotal (95% CI) 211 213 1.01 [ 0.36, 2.83 ]
Total events: 7 (PFN), 7 (Gamma nail)
Heterogeneity: not applicable
Test for overall effect: Z = 0.02 (P = 0.99)
6 Intra-operative comminution of the fracture around the trochanteric region
Herrera 2002 5/125 19/125 0.26 [ 0.10, 0.68 ]
Papasimos 2005 1/40 1/40 1.00 [ 0.06, 15.44 ]
Subtotal (95% CI) 165 165 0.30 [ 0.12, 0.73 ]
Total events: 6 (PFN), 20 (Gamma nail)
Heterogeneity: Chi2 = 0.82, df = 1 (P = 0.37); I2 =0.0%
Test for overall effect: Z = 2.67 (P = 0.0076)
7 Operative fracture of the femur
Herrera 2002 0/125 0/125 0.0 [ 0.0, 0.0 ]
Marques 2005 1/79 2/77 0.49 [ 0.05, 5.26 ]
Papasimos 2005 0/40 1/40 0.33 [ 0.01, 7.95 ]
Schipper 2004 0/211 2/213 0.20 [ 0.01, 4.18 ]
Subtotal (95% CI) 455 455 0.33 [ 0.07, 1.63 ]
Total events: 1 (PFN), 5 (Gamma nail)
Heterogeneity: Chi2 = 0.20, df = 2 (P = 0.90); I2 =0.0%
Test for overall effect: Z = 1.36 (P = 0.17)
8 Suboptimal position of fixation devices
Schipper 2004 34/211 28/213 1.23 [ 0.77, 1.95 ]
Subtotal (95% CI) 211 213 1.23 [ 0.77, 1.95 ]
Total events: 34 (PFN), 28 (Gamma nail)
Heterogeneity: not applicable
Test for overall effect: Z = 0.86 (P = 0.39)
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Analysis 1.4. Comparison 1 Proximal femoral nail (PFN) versus Gamma nail, Outcome 4 Fracture healing
complications.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 1 Proximal femoral nail (PFN) versus Gamma nail
Outcome: 4 Fracture healing complications
Study or subgroup PFN Gamma nail Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Cut-out
Herrera 2002 1/125 5/125 0.20 [ 0.02, 1.69 ]
Marques 2005 4/79 4/77 0.97 [ 0.25, 3.76 ]
Papasimos 2005 1/40 2/40 0.50 [ 0.05, 5.30 ]
Schipper 2004 11/211 13/213 0.85 [ 0.39, 1.86 ]
Subtotal (95% CI) 455 455 0.71 [ 0.39, 1.30 ]
Total events: 17 (PFN), 24 (Gamma nail)
Heterogeneity: Chi2 = 1.87, df = 3 (P = 0.60); I2 =0.0%
Test for overall effect: Z = 1.11 (P = 0.27)
2 Later fracture of femur
Herrera 2002 0/125 4/125 0.11 [ 0.01, 2.04 ]
Marques 2005 0/79 0/77 0.0 [ 0.0, 0.0 ]
Papasimos 2005 0/40 0/40 0.0 [ 0.0, 0.0 ]
Schipper 2004 4/211 1/213 4.04 [ 0.46, 35.83 ]
Subtotal (95% CI) 455 455 0.82 [ 0.24, 2.84 ]
Total events: 4 (PFN), 5 (Gamma nail)
Heterogeneity: Chi2 = 3.86, df = 1 (P = 0.05); I2 =74%
Test for overall effect: Z = 0.31 (P = 0.76)
3 Implant breakage
Herrera 2002 0/125 0/125 0.0 [ 0.0, 0.0 ]
Papasimos 2005 0/40 0/40 0.0 [ 0.0, 0.0 ]
Schipper 2004 0/211 1/213 0.34 [ 0.01, 8.21 ]
Subtotal (95% CI) 376 378 0.34 [ 0.01, 8.21 ]
Total events: 0 (PFN), 1 (Gamma nail)
Heterogeneity: Chi2 = 0.00, df = 0 (P<0.00001); I2 =100%
Test for overall effect: Z = 0.67 (P = 0.50)
4 Non-union/pseudoarthrosis
Herrera 2002 2/125 1/125 2.00 [ 0.18, 21.78 ]
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Study or subgroup PFN Gamma nail Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Papasimos 2005 0/40 1/40 0.33 [ 0.01, 7.95 ]
Schipper 2004 0/211 2/213 0.20 [ 0.01, 4.18 ]
Subtotal (95% CI) 376 378 0.60 [ 0.14, 2.50 ]
Total events: 2 (PFN), 4 (Gamma nail)
Heterogeneity: Chi2 = 1.60, df = 2 (P = 0.45); I2 =0.0%
Test for overall effect: Z = 0.70 (P = 0.49)
5 Secondary varus (> 10%)
Herrera 2002 9/125 2/125 4.50 [ 0.99, 20.41 ]
Subtotal (95% CI) 125 125 4.50 [ 0.99, 20.41 ]
Total events: 9 (PFN), 2 (Gamma nail)
Heterogeneity: not applicable
Test for overall effect: Z = 1.95 (P = 0.051)
6 Fracture site collapse due to screw migration
Herrera 2002 10/125 4/125 2.50 [ 0.81, 7.76 ]
Subtotal (95% CI) 125 125 2.50 [ 0.81, 7.76 ]
Total events: 10 (PFN), 4 (Gamma nail)
Heterogeneity: not applicable
Test for overall effect: Z = 1.59 (P = 0.11)
7 Medial or lateral hip screw migration
Schipper 2004 12/211 2/213 6.06 [ 1.37, 26.74 ]
Subtotal (95% CI) 211 213 6.06 [ 1.37, 26.74 ]
Total events: 12 (PFN), 2 (Gamma nail)
Heterogeneity: not applicable
Test for overall effect: Z = 2.38 (P = 0.017)
8 Muscle pain due to ’point effect’
Herrera 2002 4/125 7/125 0.57 [ 0.17, 1.90 ]
Subtotal (95% CI) 125 125 0.57 [ 0.17, 1.90 ]
Total events: 4 (PFN), 7 (Gamma nail)
Heterogeneity: not applicable
Test for overall effect: Z = 0.91 (P = 0.36)
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Analysis 1.5. Comparison 1 Proximal femoral nail (PFN) versus Gamma nail, Outcome 5 Reoperation.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 1 Proximal femoral nail (PFN) versus Gamma nail
Outcome: 5 Reoperation
Study or subgroup PFN Gamma nail Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Herrera 2002 6/125 9/125 25.0 % 0.67 [ 0.24, 1.82 ]
Marques 2005 5/79 3/77 8.5 % 1.62 [ 0.40, 6.56 ]
Papasimos 2005 5/40 3/40 8.3 % 1.67 [ 0.43, 6.51 ]
Schipper 2004 29/211 21/213 58.2 % 1.39 [ 0.82, 2.36 ]
Total (95% CI) 455 455 100.0 % 1.25 [ 0.83, 1.90 ]
Total events: 45 (PFN), 36 (Gamma nail)
Heterogeneity: Chi2 = 1.98, df = 3 (P = 0.58); I2 =0.0%
Test for overall effect: Z = 1.06 (P = 0.29)
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Analysis 1.6. Comparison 1 Proximal femoral nail (PFN) versus Gamma nail, Outcome 6 Wound
complications.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 1 Proximal femoral nail (PFN) versus Gamma nail
Outcome: 6 Wound complications
Study or subgroup PFN Gamma nail Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Seroma
Herrera 2002 19/125 21/125 0.90 [ 0.51, 1.60 ]
Subtotal (95% CI) 125 125 0.90 [ 0.51, 1.60 ]
Total events: 19 (PFN), 21 (Gamma nail)
Heterogeneity: not applicable
Test for overall effect: Z = 0.34 (P = 0.73)
2 Haematoma
Herrera 2002 17/125 13/125 1.31 [ 0.66, 2.58 ]
Marques 2005 8/79 11/77 0.71 [ 0.30, 1.67 ]
Papasimos 2005 3/40 2/40 1.50 [ 0.26, 8.50 ]
Schipper 2004 7/211 10/213 0.71 [ 0.27, 1.82 ]
Subtotal (95% CI) 455 455 0.97 [ 0.62, 1.51 ]
Total events: 35 (PFN), 36 (Gamma nail)
Heterogeneity: Chi2 = 1.94, df = 3 (P = 0.59); I2 =0.0%
Test for overall effect: Z = 0.15 (P = 0.88)
3 Superficial infection
Herrera 2002 3/125 4/125 0.75 [ 0.17, 3.28 ]
Papasimos 2005 1/40 0/40 3.00 [ 0.13, 71.51 ]
Schipper 2004 8/211 15/213 0.54 [ 0.23, 1.24 ]
Subtotal (95% CI) 376 378 0.65 [ 0.32, 1.29 ]
Total events: 12 (PFN), 19 (Gamma nail)
Heterogeneity: Chi2 = 1.12, df = 2 (P = 0.57); I2 =0.0%
Test for overall effect: Z = 1.24 (P = 0.22)
4 Deep infection
Herrera 2002 1/125 0/125 3.00 [ 0.12, 72.94 ]
Marques 2005 0/79 0/77 0.0 [ 0.0, 0.0 ]
Schipper 2004 5/211 6/213 0.84 [ 0.26, 2.71 ]
Subtotal (95% CI) 415 415 1.01 [ 0.34, 2.95 ]
Total events: 6 (PFN), 6 (Gamma nail)
Heterogeneity: Chi2 = 0.54, df = 1 (P = 0.46); I2 =0.0%
Test for overall effect: Z = 0.01 (P = 0.99)
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Analysis 1.7. Comparison 1 Proximal femoral nail (PFN) versus Gamma nail, Outcome 7 Post-operative
complications.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 1 Proximal femoral nail (PFN) versus Gamma nail
Outcome: 7 Post-operative complications
Study or subgroup PFN Gamma nail Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Pneumonia
Marques 2005 1/79 0/77 2.93 [ 0.12, 70.72 ]
Papasimos 2005 0/40 0/40 0.0 [ 0.0, 0.0 ]
Subtotal (95% CI) 119 117 2.93 [ 0.12, 70.72 ]
Total events: 1 (PFN), 0 (Gamma nail)
Heterogeneity: Chi2 = 0.0, df = 0 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 0.66 (P = 0.51)
2 Pressure sores
Herrera 2002 11/125 9/125 1.22 [ 0.52, 2.85 ]
Marques 2005 2/79 3/77 0.65 [ 0.11, 3.78 ]
Subtotal (95% CI) 204 202 1.08 [ 0.51, 2.30 ]
Total events: 13 (PFN), 12 (Gamma nail)
Heterogeneity: Chi2 = 0.40, df = 1 (P = 0.53); I2 =0.0%
Test for overall effect: Z = 0.19 (P = 0.85)
3 Deep vein thrombosis
Marques 2005 1/79 0/77 2.93 [ 0.12, 70.72 ]
Papasimos 2005 1/40 1/40 1.00 [ 0.06, 15.44 ]
Subtotal (95% CI) 119 117 1.65 [ 0.22, 12.29 ]
Total events: 2 (PFN), 1 (Gamma nail)
Heterogeneity: Chi2 = 0.25, df = 1 (P = 0.62); I2 =0.0%
Test for overall effect: Z = 0.49 (P = 0.63)
4 Pulmonary embolism
Herrera 2002 2/125 1/125 2.00 [ 0.18, 21.78 ]
Marques 2005 0/79 0/77 0.0 [ 0.0, 0.0 ]
Papasimos 2005 1/40 1/40 1.00 [ 0.06, 15.44 ]
Subtotal (95% CI) 244 242 1.50 [ 0.25, 8.85 ]
Total events: 3 (PFN), 2 (Gamma nail)
Heterogeneity: Chi2 = 0.14, df = 1 (P = 0.71); I2 =0.0%
Test for overall effect: Z = 0.45 (P = 0.65)
5 Acute post-operative mental confusion
Herrera 2002 15/125 20/125 0.75 [ 0.40, 1.40 ]
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Study or subgroup PFN Gamma nail Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Papasimos 2005 3/40 3/40 1.00 [ 0.21, 4.66 ]
Subtotal (95% CI) 165 165 0.78 [ 0.44, 1.39 ]
Total events: 18 (PFN), 23 (Gamma nail)
Heterogeneity: Chi2 = 0.12, df = 1 (P = 0.73); I2 =0.0%
Test for overall effect: Z = 0.83 (P = 0.40)
6 Urinary infection
Herrera 2002 8/125 6/125 1.33 [ 0.48, 3.73 ]
Papasimos 2005 1/40 2/40 0.50 [ 0.05, 5.30 ]
Subtotal (95% CI) 165 165 1.13 [ 0.44, 2.84 ]
Total events: 9 (PFN), 8 (Gamma nail)
Heterogeneity: Chi2 = 0.56, df = 1 (P = 0.45); I2 =0.0%
Test for overall effect: Z = 0.25 (P = 0.80)
7 Digestive haemorrhage
Herrera 2002 0/125 1/125 0.33 [ 0.01, 8.10 ]
Subtotal (95% CI) 125 125 0.33 [ 0.01, 8.10 ]
Total events: 0 (PFN), 1 (Gamma nail)
Heterogeneity: not applicable
Test for overall effect: Z = 0.67 (P = 0.50)
8 Acute kidney failure
Herrera 2002 1/125 2/125 0.50 [ 0.05, 5.44 ]
Subtotal (95% CI) 125 125 0.50 [ 0.05, 5.44 ]
Total events: 1 (PFN), 2 (Gamma nail)
Heterogeneity: not applicable
Test for overall effect: Z = 0.57 (P = 0.57)
0.01 0.1 1 10 100
Favours PFN Favours Gamma
Analysis 1.8. Comparison 1 Proximal femoral nail (PFN) versus Gamma nail, Outcome 8 Length of hospital
stay (days).
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 1 Proximal femoral nail (PFN) versus Gamma nail
Outcome: 8 Length of hospital stay (days)
Study or subgroup PFN Gamma Mean Difference Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Schipper 2004 211 21.7 (20.34) 213 19 (17.51) 2.70 [ -0.91, 6.31 ]
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Analysis 1.9. Comparison 1 Proximal femoral nail (PFN) versus Gamma nail, Outcome 9 Mortality.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 1 Proximal femoral nail (PFN) versus Gamma nail
Outcome: 9 Mortality
Study or subgroup PFN Gamma nail Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 At 4 months
Schipper 2004 39/211 31/213 100.0 % 1.27 [ 0.82, 1.96 ]
Subtotal (95% CI) 211 213 100.0 % 1.27 [ 0.82, 1.96 ]
Total events: 39 (PFN), 31 (Gamma nail)
Heterogeneity: not applicable
Test for overall effect: Z = 1.09 (P = 0.28)
2 At 12 months
Herrera 2002 29/125 24/125 30.0 % 1.21 [ 0.75, 1.95 ]
Marques 2005 11/79 14/77 17.7 % 0.77 [ 0.37, 1.58 ]
Schipper 2004 46/211 42/213 52.3 % 1.11 [ 0.76, 1.60 ]
Subtotal (95% CI) 415 415 100.0 % 1.08 [ 0.82, 1.41 ]
Total events: 86 (PFN), 80 (Gamma nail)
Heterogeneity: Chi2 = 1.09, df = 2 (P = 0.58); I2 =0.0%
Test for overall effect: Z = 0.53 (P = 0.60)
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Analysis 1.10. Comparison 1 Proximal femoral nail (PFN) versus Gamma nail, Outcome 10 Final functional
outcomes.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 1 Proximal femoral nail (PFN) versus Gamma nail
Outcome: 10 Final functional outcomes
Study or subgroup PFN Gamma nail Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Pain at follow up
Marques 2005 6/79 14/77 0.42 [ 0.17, 1.03 ]
2 Symptoms or restriction from the hip
Schipper 2004 16/73 16/67 0.92 [ 0.50, 1.69 ]
3 Incomplete recovery of walking ability (including death)
Herrera 2002 63/125 61/125 1.03 [ 0.80, 1.33 ]
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Analysis 1.11. Comparison 1 Proximal femoral nail (PFN) versus Gamma nail, Outcome 11 Harris hip
scores (0 to 100: high values = best function).
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 1 Proximal femoral nail (PFN) versus Gamma nail
Outcome: 11 Harris hip scores (0 to 100: high values = best function)
Study or subgroup PFN Gamma nail Mean Difference Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 At 4 weeks
Schipper 2004 140 52.6 (17.8) 139 53.9 (17.17) -1.30 [ -5.40, 2.80 ]
2 At 4 months
Schipper 2004 133 61.9 (18.45) 130 62 (19.38) -0.10 [ -4.67, 4.47 ]
3 At 1 year
Schipper 2004 73 66.8 (17.94) 64 69.5 (16) -2.70 [ -8.38, 2.98 ]
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Analysis 2.1. Comparison 2 ACE trochanteric nail versus Gamma nail, Outcome 1 Operative details: length
of surgery, blood loss and radiographic screening time.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 2 ACE trochanteric nail versus Gamma nail
Outcome: 1 Operative details: length of surgery, blood loss and radiographic screening time
Study or subgroup ACE nail Gamma nail Mean Difference Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Length of surgery (minutes)
Efstathopoulos 2007 56 54 (15) 56 51 (11) 3.00 [ -1.87, 7.87 ]
2 Operative blood loss (mls)
Vidyadhara 2007 36 63 (12) 37 50 (15) 13.00 [ 6.78, 19.22 ]
3 Units of blood transfused
Efstathopoulos 2007 56 2 (1.7) 56 2.3 (1.6) -0.30 [ -0.91, 0.31 ]
4 Radiographic screening time (minutes)
Efstathopoulos 2007 56 2.5 (1.7) 56 2.2 (1.8) 0.30 [ -0.35, 0.95 ]
-100 -50 0 50 100
Favours ACE nail Favours Gamma nail
Analysis 2.2. Comparison 2 ACE trochanteric nail versus Gamma nail, Outcome 2 Number of patients
transfused.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 2 ACE trochanteric nail versus Gamma nail
Outcome: 2 Number of patients transfused
Study or subgroup ACE nail Gamma nail Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Efstathopoulos 2007 49/56 42/56 2.33 [ 0.86, 6.32 ]
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Analysis 2.3. Comparison 2 ACE trochanteric nail versus Gamma nail, Outcome 3 Fracture healing
complications.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 2 ACE trochanteric nail versus Gamma nail
Outcome: 3 Fracture healing complications
Study or subgroup ACE nail Gamma nail Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Operative fracture of femur
Efstathopoulos 2007 0/56 0/56 0.0 [ 0.0, 0.0 ]
Vidyadhara 2007 0/36 0/37 0.0 [ 0.0, 0.0 ]
Subtotal (95% CI) 92 93 0.0 [ 0.0, 0.0 ]
Total events: 0 (ACE nail), 0 (Gamma nail)
Heterogeneity: Chi2 = 0.0, df = 0 (P<0.00001); I2 =0.0%
Test for overall effect: Z = 0.0 (P < 0.00001)
2 Later fracture of femur
Efstathopoulos 2007 0/56 0/56 0.0 [ 0.0, 0.0 ]
Vidyadhara 2007 0/36 0/37 0.0 [ 0.0, 0.0 ]
Subtotal (95% CI) 92 93 0.0 [ 0.0, 0.0 ]
Total events: 0 (ACE nail), 0 (Gamma nail)
Heterogeneity: Chi2 = 0.0, df = 0 (P<0.00001); I2 =0.0%
Test for overall effect: Z = 0.0 (P < 0.00001)
3 Cut-out
Efstathopoulos 2007 0/56 0/56 0.0 [ 0.0, 0.0 ]
Vidyadhara 2007 0/36 1/37 0.33 [ 0.01, 8.45 ]
Subtotal (95% CI) 92 93 0.33 [ 0.01, 8.45 ]
Total events: 0 (ACE nail), 1 (Gamma nail)
Heterogeneity: Chi2 = 0.0, df = 0 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 0.67 (P = 0.51)
4 Non-union
Efstathopoulos 2007 0/56 0/56 0.0 [ 0.0, 0.0 ]
Vidyadhara 2007 0/36 0/37 0.0 [ 0.0, 0.0 ]
Subtotal (95% CI) 92 93 0.0 [ 0.0, 0.0 ]
Total events: 0 (ACE nail), 0 (Gamma nail)
Heterogeneity: Chi2 = 0.0, df = 0 (P<0.00001); I2 =0.0%
Test for overall effect: Z = 0.0 (P < 0.00001)
5 All fracture healing complications
Efstathopoulos 2007 0/56 0/56 0.0 [ 0.0, 0.0 ]
Vidyadhara 2007 0/36 1/37 0.33 [ 0.01, 8.45 ]
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Study or subgroup ACE nail Gamma nail Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Subtotal (95% CI) 92 93 0.33 [ 0.01, 8.45 ]
Total events: 0 (ACE nail), 1 (Gamma nail)
Heterogeneity: Chi2 = 0.0, df = 0 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 0.67 (P = 0.51)
6 Reoperation
Efstathopoulos 2007 0/56 0/56 0.0 [ 0.0, 0.0 ]
Vidyadhara 2007 0/36 1/37 0.33 [ 0.01, 8.45 ]
Subtotal (95% CI) 92 93 0.33 [ 0.01, 8.45 ]
Total events: 0 (ACE nail), 1 (Gamma nail)
Heterogeneity: Chi2 = 0.0, df = 0 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 0.67 (P = 0.51)
0.01 0.1 1 10 100
Favours ACE nail Favours Gamma nail
Analysis 2.4. Comparison 2 ACE trochanteric nail versus Gamma nail, Outcome 4 Wound complications.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 2 ACE trochanteric nail versus Gamma nail
Outcome: 4 Wound complications
Study or subgroup ACE nail Gamma nail Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 All wound infection
Efstathopoulos 2007 4/56 3/56 1.36 [ 0.29, 6.37 ]
Vidyadhara 2007 0/36 0/37 0.0 [ 0.0, 0.0 ]
Subtotal (95% CI) 92 93 1.36 [ 0.29, 6.37 ]
Total events: 4 (ACE nail), 3 (Gamma nail)
Heterogeneity: Chi2 = 0.0, df = 0 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 0.39 (P = 0.70)
2 Deep wound infection
Efstathopoulos 2007 0/56 0/56 0.0 [ 0.0, 0.0 ]
Vidyadhara 2007 0/36 0/37 0.0 [ 0.0, 0.0 ]
Subtotal (95% CI) 92 93 0.0 [ 0.0, 0.0 ]
Total events: 0 (ACE nail), 0 (Gamma nail)
Heterogeneity: Chi2 = 0.0, df = 0 (P<0.00001); I2 =0.0%
Test for overall effect: Z = 0.0 (P < 0.00001)
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Analysis 2.5. Comparison 2 ACE trochanteric nail versus Gamma nail, Outcome 5 Post-operative
complications.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 2 ACE trochanteric nail versus Gamma nail
Outcome: 5 Post-operative complications
Study or subgroup ACE nail Gamma nail Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Deep vein thrombosis
Efstathopoulos 2007 0/56 1/56 0.33 [ 0.01, 8.21 ]
Vidyadhara 2007 0/36 0/37 0.0 [ 0.0, 0.0 ]
Subtotal (95% CI) 92 93 0.33 [ 0.01, 8.21 ]
Total events: 0 (ACE nail), 1 (Gamma nail)
Heterogeneity: Chi2 = 0.0, df = 0 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 0.68 (P = 0.50)
2 All medical complications
Efstathopoulos 2007 17/47 12/41 1.37 [ 0.56, 3.36 ]
Subtotal (95% CI) 47 41 1.37 [ 0.56, 3.36 ]
Total events: 17 (ACE nail), 12 (Gamma nail)
Heterogeneity: not applicable
Test for overall effect: Z = 0.69 (P = 0.49)
0.01 0.1 1 10 100
Favours ACE nail Favours Gamma nail
Analysis 2.6. Comparison 2 ACE trochanteric nail versus Gamma nail, Outcome 6 Anatomical restoration.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 2 ACE trochanteric nail versus Gamma nail
Outcome: 6 Anatomical restoration
Study or subgroup ACE nail Gamma nail Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Shortening (1 cm or more)
Vidyadhara 2007 1/36 2/37 0.50 [ 0.04, 5.77 ]
0.01 0.1 1 10 100
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Analysis 2.7. Comparison 2 ACE trochanteric nail versus Gamma nail, Outcome 7 Mortality.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 2 ACE trochanteric nail versus Gamma nail
Outcome: 7 Mortality
Study or subgroup ACE nail Gamma nail Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Efstathopoulos 2007 2/56 2/56 1.00 [ 0.14, 7.36 ]
Vidyadhara 2007 0/36 0/37 0.0 [ 0.0, 0.0 ]
Total (95% CI) 92 93 1.00 [ 0.14, 7.36 ]
Total events: 2 (ACE nail), 2 (Gamma nail)
Heterogeneity: Chi2 = 0.0, df = 0 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 0.0 (P = 1.0)
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Analysis 2.8. Comparison 2 ACE trochanteric nail versus Gamma nail, Outcome 8 Final functional
outcomes.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 2 ACE trochanteric nail versus Gamma nail
Outcome: 8 Final functional outcomes
Study or subgroup ACE nail Gamma nail Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Hip pain at 1 month
Vidyadhara 2007 2/36 4/37 0.49 [ 0.08, 2.83 ]
2 Limp
Vidyadhara 2007 2/36 3/37 0.67 [ 0.10, 4.25 ]
3 Difficulty in squatting
Vidyadhara 2007 11/36 10/37 1.19 [ 0.43, 3.28 ]
0.01 0.1 1 10 100
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Analysis 2.9. Comparison 2 ACE trochanteric nail versus Gamma nail, Outcome 9 Mobility score (0: no
difficulties to 9: most difficulties).
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 2 ACE trochanteric nail versus Gamma nail
Outcome: 9 Mobility score (0: no difficulties to 9: most difficulties)
Study or subgroup ACE nail Gamma nail Mean Difference Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Efstathopoulos 2007 47 7.1 (2.5) 41 7 (2.1) 0.10 [ -0.86, 1.06 ]
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Analysis 2.10. Comparison 2 ACE trochanteric nail versus Gamma nail, Outcome 10 Harris hip scores (0 to
100: high values = best function).
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 2 ACE trochanteric nail versus Gamma nail
Outcome: 10 Harris hip scores (0 to 100: high values = best function)
Study or subgroup ACE nail Gamma nail Mean Difference Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 At 4 months
Vidyadhara 2007 36 93 (3) 37 91 (2) 2.00 [ 0.83, 3.17 ]
2 At 1 year
Vidyadhara 2007 36 96 (1) 37 95 (2) 1.00 [ 0.28, 1.72 ]
3 At 2 years
Vidyadhara 2007 36 95 (1) 37 94 (2) 1.00 [ 0.28, 1.72 ]
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Analysis 3.1. Comparison 3 Gliding nail versus Gamma nail, Outcome 1 Fracture fixation complications.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 3 Gliding nail versus Gamma nail
Outcome: 1 Fracture fixation complications
Study or subgroup Gliding nail Gamma nail Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Operative fracture of femur
Fritz 1999 1/40 0/40 3.00 [ 0.13, 71.51 ]
2 Later fracture of femur
Fritz 1999 1/40 0/40 3.00 [ 0.13, 71.51 ]
3 Cut-out
Fritz 1999 0/40 3/40 0.14 [ 0.01, 2.68 ]
4 Technical complications of fixation
Fritz 1999 2/40 3/40 0.67 [ 0.12, 3.78 ]
5 Reoperation
Fritz 1999 3/40 4/40 0.75 [ 0.18, 3.14 ]
0.001 0.01 0.1 1 10 100 1000
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Analysis 3.2. Comparison 3 Gliding nail versus Gamma nail, Outcome 2 Post-operative complications.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 3 Gliding nail versus Gamma nail
Outcome: 2 Post-operative complications
Study or subgroup Gliding nail Gamma nail Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Participants with a complication
Fritz 1999 9/40 6/40 1.50 [ 0.59, 3.82 ]
2 Pressure sores (decubitus)
Fritz 1999 2/40 2/40 1.00 [ 0.15, 6.76 ]
3 Pneumonia
Fritz 1999 1/40 1/40 1.00 [ 0.06, 15.44 ]
4 Cerebrovascular accident
Fritz 1999 2/40 1/40 2.00 [ 0.19, 21.18 ]
5 Apoplexy
Fritz 1999 1/40 0/40 3.00 [ 0.13, 71.51 ]
6 Forearm fracture
Fritz 1999 1/40 0/40 3.00 [ 0.13, 71.51 ]
0.001 0.01 0.1 1 10 100 1000
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Analysis 3.3. Comparison 3 Gliding nail versus Gamma nail, Outcome 3 Anatomical deformity.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 3 Gliding nail versus Gamma nail
Outcome: 3 Anatomical deformity
Study or subgroup Gliding nail Gamma nail Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Leg shortening > 2 cm
Fritz 1999 1/34 3/34 0.33 [ 0.04, 3.05 ]
2 External rotation > 20 degrees
Fritz 1999 0/34 0/34 0.0 [ 0.0, 0.0 ]
3 Internal rotation > 20 degrees
Fritz 1999 2/34 2/34 1.00 [ 0.15, 6.70 ]
0.001 0.01 0.1 1 10 100 1000
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Analysis 3.4. Comparison 3 Gliding nail versus Gamma nail, Outcome 4 Mortality at 6 months.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 3 Gliding nail versus Gamma nail
Outcome: 4 Mortality at 6 months
Study or subgroup Gliding nail Gamma nail Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Fritz 1999 6/40 5/40 1.20 [ 0.40, 3.62 ]
0.1 0.2 0.5 1 2 5 10
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Analysis 3.5. Comparison 3 Gliding nail versus Gamma nail, Outcome 5 Residence and unfavourable
outcome (geriatric institution or death) at 6 months.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 3 Gliding nail versus Gamma nail
Outcome: 5 Residence and unfavourable outcome (geriatric institution or death) at 6 months
Study or subgroup Gliding nail Gamma nail Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Living in an geriatric institution
Fritz 1999 14/34 19/34 0.74 [ 0.45, 1.22 ]
2 Unfavourable outcome (institutionalised or dead)
Fritz 1999 20/40 24/40 0.83 [ 0.56, 1.24 ]
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Analysis 4.1. Comparison 4 Russell-Taylor Recon nail versus long Gamma nail, Outcome 1 Fracture healing
and wound healing complications.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 4 Russell-Taylor Recon nail versus long Gamma nail
Outcome: 1 Fracture healing and wound healing complications
Study or subgroup Recon nail Long Gamma nail Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Operative fracture of femur
Starr 2006 0/17 0/17 0.0 [ 0.0, 0.0 ]
2 Later fracture of femur
Starr 2006 0/17 0/17 0.0 [ 0.0, 0.0 ]
3 Cut-out
Starr 2006 0/17 0/17 0.0 [ 0.0, 0.0 ]
4 Non-union
Starr 2006 0/17 0/17 0.0 [ 0.0, 0.0 ]
5 All fracture healing complications
Starr 2006 0/17 0/17 0.0 [ 0.0, 0.0 ]
6 Wound infection (any type)
Starr 2006 0/17 1/17 0.31 [ 0.01, 8.27 ]
7 Deep wound infection
Starr 2006 0/17 0/17 0.0 [ 0.0, 0.0 ]
8 Reoperation
Starr 2006 8/17 5/17 2.13 [ 0.52, 8.76 ]
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Analysis 4.2. Comparison 4 Russell-Taylor Recon nail versus long Gamma nail, Outcome 2 Final outcome
measures.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 4 Russell-Taylor Recon nail versus long Gamma nail
Outcome: 2 Final outcome measures
Study or subgroup Recon nail Long Gamma nail Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Mortality
Starr 2006 0/17 0/17 0.0 [ 0.0, 0.0 ]
2 Non-independent ambulator
Starr 2006 0/15 1/13 0.27 [ 0.01, 7.19 ]
3 Unable to do the same work
Starr 2006 2/15 2/13 0.85 [ 0.10, 7.04 ]
0.01 0.1 1 10 100
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Analysis 5.1. Comparison 5 Dynamic versus static locked intramedullary nail, Outcome 1 Operative details.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 5 Dynamic versus static locked intramedullary nail
Outcome: 1 Operative details
Study or subgroup Dynamic locking Static locking Mean Difference Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Length of surgery (minutes)
Hardy 2003 41 58.4 (17.9) 39 58.2 (14.8) 0.20 [ -6.98, 7.38 ]
2 Intra-operative blood loss (minutes)
Hardy 2003 41 142.4 (82.42) 39 133.6 (88.54) 8.80 [ -28.73, 46.33 ]
3 Haemoglobin level: 48 hours post-op (g/dL)
Hardy 2003 41 9.1 (1.05) 39 9.2 (1.32) -0.10 [ -0.62, 0.42 ]
4 Transfused packed blood cells
Hardy 2003 41 0.9 (1.03) 39 1.1 (1.06) -0.20 [ -0.66, 0.26 ]
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Analysis 5.2. Comparison 5 Dynamic versus static locked intramedullary nail, Outcome 2 Fracture fixation
complications.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 5 Dynamic versus static locked intramedullary nail
Outcome: 2 Fracture fixation complications
Study or subgroup Dynamic locking Static locking Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Later fracture of the femur
Hardy 2003 0/41 1/39 0.32 [ 0.01, 7.57 ]
2 Cut-out
Hardy 2003 1/41 0/39 2.86 [ 0.12, 68.10 ]
3 Technical complications of fixation
Hardy 2003 1/41 1/39 0.95 [ 0.06, 14.69 ]
4 Reoperation
Hardy 2003 1/41 3/39 0.32 [ 0.03, 2.92 ]
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Analysis 5.3. Comparison 5 Dynamic versus static locked intramedullary nail, Outcome 3 Leg shortening
(mm) in those able to undergo a radiographic assessment.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 5 Dynamic versus static locked intramedullary nail
Outcome: 3 Leg shortening (mm) in those able to undergo a radiographic assessment
Study or subgroup Dynamic locking Static locking Mean Difference Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Hardy 2003 21 7.6 (5.37) 26 6.3 (5.07) 1.30 [ -1.71, 4.31 ]
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Analysis 5.4. Comparison 5 Dynamic versus static locked intramedullary nail, Outcome 4 Mortality at 1
year.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 5 Dynamic versus static locked intramedullary nail
Outcome: 4 Mortality at 1 year
Study or subgroup Dynamic locking Static locking Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Hardy 2003 7/41 9/39 0.74 [ 0.31, 1.79 ]
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Analysis 5.5. Comparison 5 Dynamic versus static locked intramedullary nail, Outcome 5 Pain and cortical
hypertrophy.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 5 Dynamic versus static locked intramedullary nail
Outcome: 5 Pain and cortical hypertrophy
Study or subgroup Dynamic locking Static locking Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Mid-thigh pain
Hardy 2003 2/33 6/30 0.30 [ 0.07, 1.39 ]
2 Cortical hypertrophy
Hardy 2003 1/34 6/30 0.15 [ 0.02, 1.15 ]
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A P P E N D I C E S
Appendix 1. Search strategies (The Cochrane Library, MEDLINE and EMBASE)
The Cochrane Library MEDLINE (OVID WEB) EMBASE (OVID WEB)
#1MeSHdescriptorHip Fractures explode
all trees
#2 ((hip* or femur* or femoral* or
trochant* or pertrochant* or intertrochant*
or subtrochant* or intracapsular* or extra-
capsular*)NEAR fracture*):ti,ab,kw
#3 (#1 OR #2)
#4 4 (pin* or nail* or screw* or plate* or
arthroplasty* or fix* or prosthes*):ti,ab,kw
#5 MeSH descriptor Internal Fixators, this
term only
#6 MeSH descriptor Bone Screws, this
term only
#7 MeSH descriptor Fracture Fixation, In-
ternal explode all trees
#8MeSH descriptor Bone Plates, this term
only
#9 MeSH descriptor Bone Nails, this term
only
#10 MeSH descriptor Arthroplasty ex-
plode all trees
#11 (#4 OR #5 OR #6 OR #7 OR #8 OR
#9 OR #10)
#12 (#3 AND #11)
1. exp Hip Fractures/
2. hip$ or femur$ or femoral$ or trochant$
or pertrochant$ or intertrochant$ or sub-
trochant$ or intracapsular$ or extracapsu-
lar$)adj4 fracture$).tw.
3. or/1-2
4. (pin$1 or nail$ or screw$1 or plate$1 or
arthroplast$ or fix$ or prosthes$).tw.
5. Internal Fixators/ or Bone Screws/ or
Fracture Fixation, Internal/ or Bone Plates/
or Bone Nails/
6. Arthroplasty/or Arthroplasty, Replace-
ment, Hip/
7. or/4-6
8. and/3,7
1. exp Hip Fracture/
2. ((hip$ or femur$
or femoral$ or trochant$ or pertrochant$
or intertrochant$ or subtrochant$ or intra-
capsular$ or extracapsular$)adj4 fracture$)
.tw.
3. or/1-2
4. (pin$1 or nail$ or screw$1 or plate$1 or
arthroplast$ or fix$ or prosthes$).tw.
5. Bone Screws/ or Fracture Fixation/
or Bone Plate/ or Bone Nail/ or in-
tramedullary nailing/
6. arthroplasty/or hip arthroplasty/
7. or/4-6
8. and/3,7
9. exp Randomized Controlled trial/
10. exp Double Blind Procedure/
11. exp Single Blind Procedure/
12. exp Crossover Procedure/
13. Controlled Study/
14. or/9-13
15. ((clinical or controlled or comparative
or placebo or prospective$ or randomi#ed)
adj3 (trial or study)).tw.
16. (random$ adj7 (allocat$ or allot$ or
assign$ or basis$ or divid$ or order$)).tw.
17. ((singl$ or doubl$ or trebl$ or tripl$)
adj7 (blind$ or mask$)).tw.
18. (cross?over$ or (cross adj1 over$)).tw.
19. ((allocat$ or allot$ or assign$ or divid$)
adj3 (condition$ or experiment$ or inter-
vention$ or treatment$ or therap$ or con-
trol$ or group$)).tw.
20. or/15-19
21. or/14,20
22. limit 21 to human
23. and/8,22
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WH A T ’ S N E W
Last assessed as up-to-date: 28 June 2007.
31 July 2008 New search has been performed For the second update, published in Issue 4, 2008, the following changes were
made:
(1) the search was updated to June 2007;
(2) three newly identified studies (Efstathopoulos 2007, Starr 2006, Vidadhura
2007) were included resulting in the addition of two new comparisons;
(3) one newly identified study (Suckel 2006) was excluded.
There were no changes made to the conclusions.
30 July 2008 Amended Converted to new review format.
H I S T O R Y
Protocol first published: Issue 4, 2004
Review first published: Issue 2, 2005
17 May 2006 New search has been performed For the first update, published in Issue 3, 2006, the following changes were made:
(1) the search was updated to March 2006;
(2) two new studies (Marques 2005; Papasimos 2005) were included;
(3) additional data were included from Schipper 2004 after correspondence with
trialists;
(4) adjustments were made to text and tables to conform to revised methodology
and the Cochrane Style Guide.
There were no changes made to the conclusions.
C O N T R I B U T I O N S O F A U T H O R S
Martyn Parker initiated the review and wrote the first draft of the protocol. Helen Handoll revised the protocol. Both authors identified
trials, selected trials for inclusion, performed data extraction and quality assessment of the included trials. Martyn Parker compiled
the first draft of the review and review updates: these were then critically revised and completed by Helen Handoll. Both reviewers are
guarantors of the review.
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D E C L A R A T I O N S O F I N T E R E S T
None known.
S O U R C E S O F S U P P O R T
Internal sources
• University of Teesside, Middlesbrough, UK.
• Peterborough and Stamford Hospitals NHS Foundation Trust, UK.
External sources
• No sources of support supplied
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
The title of the review was changed in Issue 2, 2005 from that of the protocol (Cephalocondylic intramedullary nails for extracapsular
hip fractures in adults) to the present title. This reflected the expansion of the scope to include condylocephalic nails.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Bone Nails; Fracture Fixation, Intramedullary [instrumentation; ∗methods]; Hip Fractures [∗surgery]; Randomized Controlled Trials
as Topic
MeSH check words
Aged; Female; Humans; Male
54Intramedullary nails for extracapsular hip fractures in adults (Review)
Copyright © 2008 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
